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Molecular Motors of ESX-type Secretion Systems 
Abstract 
 
Tuberculosis is an enormous global health problem.  Despite decades of research, the 
mechanism(s) by which Mycobacterium tuberculosis (Mtb) mediates virulence remains 
incompletely understood.  The ESX-1 secretion system is critical for Mtb to survive and cause 
disease in vivo, but its primary function and mechanism of action are unclear.  The many inherent 
challenges of working with this slow-growing pathogen often limit the experimental approaches 
that can be used to address these questions.  Thus, we have developed a model system in the 
nonpathogenic bacterium Bacillus subtilis to study ESX-type secretion systems.  Here, we 
demonstrate that the B. subtilis yuk operon encodes an ESX-type secretion system responsible for 
the secretion of YukE.  Additionally, we demonstrate that the yuk system is active in B. subtilis 
during conditions of nutrient deprivation and is required for normal biofilm formation.  
Interestingly, this is similar to our findings that the Mtb ESX-1 system plays dual roles in protein 
secretion and modulating cell wall integrity.   
 
One defining feature of all ESX loci is the presence of an FtsK/SpoIIIE family ATPase.  
Interestingly, these ATPases have a domain structure unique to ESX-associated ATPases, where 
each protein contains multiple (2-3) enzymatic domains.  We used our B. subtilis system to 
dissect the mechanism of action of this unique class of motor proteins.  We find that the yuk-
encoded ATPase YukBA dimerizes to form a hexamer of enzymatic subunits that are 
differentially required for secretion.  Strikingly, we find a unique requirement for rotational 
symmetry in the nucleotide binding activity of the subunits. 
 
iv 
 
Finally, we compared the energy requirements of the Mtb ESX-1 system and the B. subtilis yuk 
system.  We find that these systems have some overlapping ATPase requirements for protein 
secretion and cell wall integrity/biofilm formation, suggesting that there is a conservation of 
function among ESX-type systems.  We also find that some ATPase domains are differentially 
required for function between these two systems, which we postulate is due to the split protein 
architecture of the ESX-1-encoded ATPases.  Together, these findings highlight the power of 
using a B. subtilis model system to understand the function and mechanism of action of ESX-type 
secretion systems. 
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1.1 Bacterial protein secretion systems 
 
Pathogens have evolved a variety of mechanisms to manipulate the host, and often these 
mechanisms are dependent upon the interaction of a secreted bacterial effector with a particular 
host cell target (Finlay 1997).  These substrates, whether they are proteins, lipids, or small 
molecules, must first gain access to the proper host cell environment.  This requires the transport 
of the substrate from the bacterial cytoplasm, across the cell membrane(s) and cell wall, where 
the substrate ultimately remains attached to the bacterial cell surface and is exposed to the 
extracellular environment, is secreted into the extracellular milieu, or is translocated directly into 
the host cell cytosol.  Thus, bacterial secretion systems are essential mediators of virulence for 
many pathogens. 
 
Bacterial secretion systems are also required for a diverse array of homeostatic functions.  Thus, 
bacteria have evolved a conserved set of mechanisms and systems to mediate the export of 
substrates out of the cell.  The most common mechanisms for protein secretion across the 
bacterial inner membrane are the general secretory Sec pathway and the twin arginine 
translocation TAT pathway.  Found in all bacteria, these systems transport unfolded and folded 
proteins, respectively.  Substrates of the Sec pathway are recognized by an N-terminal signal 
sequence, which is cleaved as part of the export process.  Likewise, substrates of the TAT system 
are targeted for secretion by a similar N-terminal signal sequence which includes a double 
arginine motif.  
 
For Gram-negative bacteria, protein secretion requires the substrate to traverse both the inner 
plasma membrane and an outer membrane.  To deal with this second barrier, Gram-negative 
species have evolved a number of strategies to move substrates from the cytoplasm to the 
extracellular environment.  These specialized secretion systems, numbered type I thru type VI, 
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can either be a one step process, where the secretion machinery spans from the bacterial 
cytoplasm through the entire cell envelope, or a two step process, first requiring a substrate to be 
translocated across the inner membrane by the Sec or TAT translocon (Finlay 1997).   
 
Secretion by type III and type IV systems adds another layer of complexity, as these systems 
transport substrates across a third lipid bilayer, the host cell plasma membrane.  The type III 
secretion machine is a complex structure which terminates in a needle-like complex that projects 
from the bacterial surface (Galan 1999).  Upon contact with a eukaryotic host cell, a highly 
regulated process ensues, resulting in the translocation of protein effectors through the needle’s 
inner channel and into the host cell.  Type IV secretion systems have a wide range of functions 
including DNA conjugation, DNA uptake, DNA release, protein secretion, and the injection of 
virulence factors into eukaryotic host cells (Cascales 2003).  Similar to type III systems, the type 
IV secretion machine relies on a surface protruding pilus structure to deliver protein and DNA 
effectors to the host cell. 
 
Protein secretion by Gram-positive bacteria has historically been thought to be less complex in 
comparison to their Gram-negative counterparts, as substrates have only one bacterial cell 
membrane to cross. Thus, Gram-positive organisms were not thought to require specialized 
secretion systems, although the over simplification of this belief has become increasingly 
apparent over the past decade.  Often, a typical Sec or TAT signal sequence is sufficient to direct 
the secretion of a protein across the cytoplasmic membrane and peptidoglycan layer into the 
extracellular environment.  Some proteins are targeted to the cell wall and remain anchored in the 
peptidoglycan layer through a hydrophobic targeting motif (LPXTG) at their C-terminus (Finlay 
1997).   
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Mycobacterial species, which are neither truly Gram-negative nor Gram-positive, represent a 
unique set of challenges in terms of protein secretion.  In addition to a classical inner membrane 
and a thick layer of peptidoglycan common to Gram-positive bacteria, mycobacteria have an 
additional impermeable barrier made up of mycolic acids (often called the mycomembrane), and 
more distally, a layer of lipids and glycolipids (Brennan 1995).  While mycobacteria use the well-
conserved Sec and TAT systems to secrete proteins across the inner membrane, it is still unclear 
how bacterial proteins traverse the waxy coat of this bacterium to reach the extracellular milieu.     
The genus Mycobacterium is composed of both nonpathogenic and pathogenic species, including 
human pathogens Mycobacterium tuberculosis and Mycobacterium leprae.  Given that the 
lifestyle of mycobacterial pathogens involves intimate interactions between the bacterium and the 
host cell, it would seem advantageous for these species to encode a type III- or type IV-like 
secretion system, as is the precedent set by many intracellular pathogens.  But, comprehensive 
genomic analysis revealed no such homologous system.  Within the last decade, the identification 
and characterization of a specialized secretion system present in mycobacteria has provided new 
insight into the complexities and variety of bacterial protein secretion systems. 
 
1.2 Mycobacterium tuberculosis 
 
Mycobacterium tuberculosis (Mtb), the causative agent of the disease tuberculosis (TB), is a 
devastating human pathogen and worldwide health problem.  In 2009, the World Health 
Organization reported over 9 million new cases and 1.7 million deaths (World Health 
Organization 2010).  Although this is a treatable disease, the lack of an effective vaccine, the 
prevalence of TB in the immunocompromised HIV-infected population, and the recent emergence 
of highly drug resistant strains presents a continuing challenge for global control.   
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Upon inhalation, Mtb takes up residence in the host lung to either cause active disease or develop 
into a latent infection.  Active disease is characterized by robust bacterial replication and a 
counteracting host immune response, which together lead to the clinical manifestations of the 
disease.  Conversely, a latent infection is asymptomatic and can persist for decades.  Though the 
details of latency are poorly understood, Mtb has evolved mechanisms to promote its own 
persistence and viability, while the host is able to locally contain and control the infection.   
These bacteria retain the ability to transition into an active disease state at a later time, often upon 
compromise of the host immune system, commonly as a consequence of disease or aging.  
 
The interaction between a host and pathogen is dynamic and complex.  As a successful human 
pathogen, Mtb actively avoids clearance by the immune system to ensure its own survival.  
Within the lung, Mtb resides in macrophages, modulating the function of these professional 
phagocytic cells to create a protective niche for itself.  The bacterium enters the macrophage 
through the binding of various phagocytic receptors, including complement receptors and 
mannose receptors (Ernst 1998).  Upon phagocytosis, the bacterium finds itself in an early 
phagosome.  Normally, the phagosome goes through a maturation process involving fusion with 
the lysosome to create an environment hostile to the invading microbe, characterized by low pH, 
reactive oxygen species, and lysosomal enzymes.  Intracellular pathogens have evolved a variety 
of mechanisms designed to stop this process and avoid being killed.  Mtb specifically targets an 
early step in the process of vesicle maturation by inhibiting fusion of the bacteria-containing 
phagosome with lysosomes (Armstrong 1971).  Additionally, Mtb is able to minimize 
acidification of the vacuole by excluding proton-pumping ATPases from the compartment in 
which it resides (Sturgill-Koszycki 1994).  In the end, this active ability of Mtb to modulate the 
macrophage and its antimicrobial defense mechanisms results in the creation of a protective niche 
in which to replicate and persist.   
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1.3 ESX-1 identification 
 
Though the mechanisms by which Mtb promotes its own survival are complex, it was long ago 
recognized that secreted proteins play an integral role in the host-pathogen interaction, as secreted 
proteins were identified as being the most potent T-cell antigens during an Mtb infection.  In an 
effort to understand the immune response to this pathogen, proteins in short term culture filtrates 
of in vitro grown Mtb cultures were analyzed.  Among secreted proteins, the most highly 
immunogenic antigens were found to be proteins with molecular masses between 3-9 kDa and 25-
31 kDa (Andersen 1993).  Purification and characterization experiments identified the dominant 
low molecular weight antigen to be the protein subsequently named 6 kDa early secretory 
antigenic target, or ESAT-6 (Andersen 1995, Sørensen 1995).  Subsequently, ESAT-6 was found 
to be co-transcribed with a second gene encoding for a secreted protein later named 10 kDa 
culture filtrate protein, or CFP-10 (Berthet 1998).  Both ESAT-6 and CFP-10 are small, 100 
amino acid proteins with no homology to known proteins.  Most interestingly, both proteins lack 
a canonical signal sequence for the general secretory pathway.  These findings suggested that Mtb 
may use a specialized secretion system to export ESAT-6 and CFP-10 during infection. 
 
In silico analysis, made possible by the completion of the whole genome sequence of the most 
well characterized laboratory strain of Mtb, H37Rv, revealed that ESAT-6 is part of a larger gene 
family consisting of 14 members.  Interestingly, five of these ESAT-6 family proteins are 
encoded within genetic loci with a highly conserved organization (Cole 1998, Tekaia 1999).  
These five gene clusters, originally named ESAT-6 cluster regions 1-5, are the result of genetic 
duplication events (Gey van Pittus 2001).  In addition to the pair of ESAT-6 and CFP-10 family 
proteins encoded within each locus, these loci also contain a conserved set of genes 
encompassing various protein families, including PE/PPE proteins, ABC transporters, ATP-
binding proteins, large multi-pass transmembrane proteins, and integral membrane proteins of 
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unknown function (Tekaia 1999).  The features and conservation of these gene clusters led 
multiple groups to hypothesize that these loci may encode a secretion apparatus responsible for 
the transport of ESAT-6 and CFP-10 family proteins across the inner cell membrane and/or the 
cell wall (Cole 1998, Tekaia 1999, Gey van Pittius 2001, Pallen 2002). 
 
Concurrent to the genetic and proteomic characterization of Mtb, studies of virulence highlighted 
the importance of one specific ESAT-6 gene cluster, region 1, in the pathogenesis of this 
bacterium.  Clues to identifying the major virulence determinants of Mtb came from the study of 
Mycobacterium bovis Bacille Calmette-Guerin (M. bovis BCG).  The serial passage of the 
virulent bovine pathogen M. bovis over multiple decades resulted in an attenuated strain, M. bovis 
BCG, which has been used as a live attenuated vaccine against tuberculosis for nearly a century.  
Through genetic comparison of M. bovis BCG, virulent M. bovis and Mtb H37Rv, it was 
suggested that the primary attenuating deletion of the M. bovis BCG strain was the loss of a 9.5-
kb segment of DNA designated RD1 (Mahairas 1996).  Included within this genomic region are 
the genes for the abundantly secreted antigens ESAT-6 and CFP-10.  The hypothesis that the loss 
of RD1 was the major attenuating deletion of M. bovis BCG was later experimentally supported, 
as the reintroduction of the RD1 locus into M. bovis BCG significantly restored the virulence of 
this strain in mice, though not fully to the levels of wild-type M. bovis (Pym 2002).  More 
directly, when the precise RD1 deletion from M. bovis BCG was recreated in pathogenic Mtb 
H37Rv, it resulted in an attenuation of virulence in both macrophages and mice (Lewis 2003). 
 
The role of RD1 in virulence was again highlighted by experiments to comprehensively define 
the requirements for Mtb growth in vitro and in vivo.  Transposon mutations within this genetic 
region did not affect growth of the bacterium in vitro, but these genes were found to be essential 
for growth in both mice and macrophages (Sassetti 2003a, Sassetti 2003b, Rengarajan 2005).  
The identification of multiple RD1-encoded genes as being individually required for virulence 
8 
 
added support to the hypothesis that these genes act together as a functional unit to directly 
mediate Mtb pathogenesis.   
 
The 9.5 kb genetic region defining RD1 is part of a larger genetic locus initially termed ESAT-6 
gene cluster region 1.  This locus was later more precisely defined to include genes Rv3864-
Rv3883 (espE –mycP1 ) and was named ESAT-6 system-1, or ESX-1 (Brodin 2004).  In 2009, a 
systematic nomenclature for defining the components of ESX loci was adopted (Figure 1-1) 
(Bitter 2009).  To keep within these guidelines, the ESX system components referred to in this 
document will from here on follow this accepted nomenclature. 
 
 
Figure 1-1.  Genetic organization of the Mycobacterium tuberculosis ESX-1 locus. 
Schematic depicting the ESX-1 locus (top) and espA operon (bottom).  Genes highlighted in blue 
(eccCa and eccCb) encode the FtsK/SpoIIIE family ATPases relevant to this dissertation.  Genes 
highlighted in red encode the conserved substrates EsxA and EsxB. 
 
The genes of ESX-1 were hypothesized to play a direct role in pathogenesis by encoding a 
specialized secretion system responsible for the translocation of virulence effectors.  To begin to 
test this hypothesis, multiple groups took similar genetic approaches to test the effects of 
individual ESX-1 gene disruptions on secretion and virulence.  Mutations, either through 
transposon insertion or gene deletion, in eccCa, eccCb, esxA, esxB, espI, and eccD were found to 
abolish the secretion of EsxA and EsxB (formerly ESAT-6 and CFP-10) (Stanley 2003, Guinn 
2004).  To directly test the hypothesized association between ESX-1 secretion and virulence, 
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individual ESX-1 mutants were assayed in macrophage and mouse models of infection.  Secretion 
defective strains with mutations in eccCa, eccCb, or eccD showed delayed growth kinetics, a less 
robust inflammatory response, and decreased overall virulence in mice (Stanley 2003).  Similarly, 
Guinn et al. showed that mutants lacking individual ESX-1 genes phenocopied an RD1 mutant 
strain in mice and macrophage infections, demonstrating defects in growth, inflammation, and 
cytotoxicity (2004).  Together, these data support the prediction that the ESX-1 locus encodes for 
the components of a secretion system that work together to translocate the locus-encoded proteins 
EsxA and EsxB.  Furthermore, the secretion of these proteins is coupled to Mtb pathogenesis, as 
any strain capable of secreting EsxA and EsxB shows wild-type levels of growth and 
pathogenicity in models of infection, while any ESX-1 mutant defective for secretion is 
attenuated for virulence.  The fact that the disruption of a single gene attenuates the bacterium to 
the same extent as deleting the entire locus again provides evidence that the genes within this 
locus work together as a functional unit. 
 
1.4 Components and mechanism of the ESX-1 secretion system  
 
To better understand how ESX-1 functions to mediate virulence, we can first aim to understand 
the mechanism by which ESX-1 assembles and exports proteins.  By combining functional and 
structural predictions with protein-protein interaction studies, insight into the molecular 
mechanism of the ESX-1 secretion system can be gained.  To date, six ESX-1 substrates have 
been identified.  The originally identified substrates, EsxA and EsxB, form a tight, heterodimeric 
complex and are dependent on one another for stability and secretion (Renshaw 2002).  EspA, 
EspB and EspC are also substrates of the ESX-1 system (Fortune 2005, Xu 2007, McLaughlin 
2007, MacGurn 2005).  espA and espC, along with a third gene, espD, are encoded within a 
second gene cluster unlinked to the ESX-1 locus.  Unusually, these five substrates are mutually 
dependent upon one another for secretion, as deletion of any one substrate abolishes the secretion 
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of all other substrates (Fortune 2005).  The molecular basis for this codependence is unclear; 
these proteins may be secreted as part of a multimeric complex, or alternatively, these proteins 
may be structural components of the secretion system, and the stability of the transport machine 
could require the presence of each component (Fortune 2005).  Lastly, a DNA-binding 
transcription factor, EspR, is also an ESX-1 secreted substrate (Raghavan 2008).  EspR binds and 
activates transcription of the espACD operon and is itself secreted, thereby downregulating espA 
expression, creating a negative feedback loop to regulate secretion. 
 
The ESX-1 substrates are hypothesized to be translocated across the inner cell membrane through 
a pore created by the multipass transmembrane protein EccD, though this prediction has not been 
experimentally demonstrated.  The mechanism by which the ESX-1 substrates are translocated 
across the mycobacterial cell wall is currently unclear.  The energy for substrate translocation is 
thought to be provided by the locus-encoded proteins EccCa and EccCb.  EccCa contains N-
terminal transmembrane domains, which presumably anchor the protein into the cytosolic face of 
the inner membrane, and a single ATPase domain of the FtsK/SpoIIIE family.  EccCb contains 
two like ATPase domains.  EccCa and EccCb are predicted to act as a single functional unit, 
because in other Mtb ESX loci, these proteins are encoded for by a single open reading frame, 
which was divided into two separate genes during the evolution of the ESX-1 genetic duplication 
(Gey van Pittus 2001).  This prediction is supported by the demonstration that EccCa and EccCb 
interact in vitro, by a yeast two-hybrid assay (Stanley 2003).   
 
An in vitro yeast two-hybrid system also identified an interaction between the C-terminus of 
EccCb and the substrate EsxB (Stanley 2003).  A subsequent study identified the last 7 amino 
acids of EsxB as being both necessary and sufficient for the interaction with EccCb (Champion 
2006).  These 7 amino acids are part of the unstructured C-terminal tail of EsxB, which remains 
exposed upon formation of the EsxA:EsxB dimer.  Therefore, it is believed that the EsxB signal 
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sequence targets the EsxA:EsxB dimer for secretion.  Similarly, the C-terminus of the substrate 
EspC was also shown to be required for interaction with another ESX-1-encoded ATPase, EccA 
(Champion 2009).  EccA is a cytosolic protein of the AAA ATPase family, which has been 
shown to possess functional enzymatic activity and to self hexamerize in vitro (Luthra 2008).  
The C-terminal sequences of EspC and EsxB are functionally distinct, and unlike the EsxB C-
terminal sequence, the EspC sequence is necessary, but not sufficient for secretion (Champion 
2009).  
 
1.5 Two models of ESX-1 function 
 
While the identification of the ESX-1 secretion system as a major determinant in the pathogenesis 
of Mtb has been well recognized, the mechanism by which this system mediates virulence is still 
poorly understood.  Traditionally, ESX-1 was believed to mediate virulence through the secretion 
of a small number of protein substrates directly into the host cell.  While this is an enticing model, 
a mechanism by which the known ESX-1 substrates might act on the host cell is unclear, as none 
of these proteins contain conserved functional domains that would suggest a mechanism by which 
the proteins would act as virulence effectors.   
 
There has been some evidence to suggest that EsxA has pore forming abilities and may act as an 
effector of host cell cytolysis, though this idea remains controversial.  Using an artificial 
membrane system Hsu et al. showed that purified EsxA could disrupt a lipid bilayer (2003).  Also 
using an in vitro system, de Jonge et al. demonstrated a strong association between purified EsxA 
and liposomes, which resulted in the destabilization and lysis of the liposomes (2007).  But, when 
EsxA is present in a 1:1 complex with EsxB, these proteins no longer associate with liposomes.  
The in vivo relevance of these findings are questionable, as structural studies have demonstrated 
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the extreme stability of the EsxA:EsxB dimer, leading multiple groups to conclude that the 
biologically active form of these proteins is as a complex (Renshaw 2002, Lightbody 2008).   
 
Further complicating the model that the primary mechanism of ESX-1-associated virulence is 
mediated by the pore-forming ability of EsxA is the conservation of ESX-1 and esxA in 
nonpathogenic bacterial species.  This includes nonpathogenic mycobacteria, such as the soil-
dwelling species Mycobacterium smegmatis, as well as various Gram-positive species, both 
pathogenic and nonpathogenic (Gey van Pittius 2001, Pallen 2002).  It is unclear how a conserved 
virulence effector such as EsxA would benefit organisms representing such diverse bacterial 
lifestyles.  It is possible that EsxA has evolved functions specific to the needs of each organism 
or, the ESX system of each organism may secrete a different set of substrate proteins, specific to 
the environmental niche in which it resides.   
 
Alternatively, ESX systems may have a common function representing a more basic, homeostatic 
process.  It is known that the mycobacterial cell wall is a complex structure, and proper assembly 
and maintenance of this structure is critical for the survival of the bacterium, both in vitro and in 
vivo.  Indeed, the connection between colony morphology, often a gross readout of cell wall 
composition, virulence, and ESX-1 was long ago recognized.  Steenken et al. isolated 
mycobacterial colonial variants and demonstrated a strong association between variations in 
morphology and differences in virulence in various animal models (1934, Petroff 1930).  
Interestingly, the attenuated strains Mtb H37Ra and M. bovis BCG were originally isolated from 
populations of virulent Mtb H37Rv and M. bovis, respectively, based on a change in colony 
morphology (Calmette 1927, Steenken 1938).  It is hypothesized that this change in morphology 
coincided with the loss of ESX-1 function and the resulting attenuation of these strains (Pym 
2002, Frigui 2008).  When the ESX-1 locus was reintroduced into M. bovis BCG both virulence 
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and colony morphology reverted to that of M. bovis and Mtb H37Rv (Pym 2002).  These 
observations suggest that ESX-1 plays a role in modulating the mycobacterial cell wall. 
 
In validation of the above observations, Garces et al. recently demonstrated that ESX-1 is a 
critical mediator of cell wall integrity, and it is hypothesized that it is through this function that 
ESX-1 mediates virulence, independent of protein secretion (2010).  This suggests that the 
primary target of ESX-1 is the mycobacterial cell wall.  It is possible that an ESX-1 substrate, 
perhaps the substrate protein EspA, modifies a component of the cell wall, or alternatively, ESX-
1 may be responsible for the translocation of cell wall components.  The loss of cell wall integrity 
that occurs due to ESX-1 mutations may detrimentally affect the host-pathogen interaction, 
leading to the observed virulence defects of the strains in the above study.   
 
Many details of the biology of the ESX-1 system remain to be elucidated.  However, the inherent 
difficulties of working with pathogenic Mtb have thus far hindered our ability to manipulate this 
pathogen in the robust manner necessary to address the detailed mechanistic questions required 
for the understanding of ESX-1 function on a molecular level.  But, ESX-type secretion systems 
are conserved throughout Gram-positive bacteria, many of which are nonpathogenic, thereby 
providing an opportunity to gain insight into the function(s) and mechanism of action of ESX-
type secretion systems using a more tractable bacterial model.   
 
1.6 Gram-positive ESX-type secretion systems 
 
The identification of ESX-type secretion systems in other bacterial species stemmed from the 
increasing recognition of the importance of EsxA-like proteins in mycobacteria, which led to the 
use of in silico methods to search for EsxA homologues in other bacteria.  Homologues were first 
identified in the phyla actinobacteria (high G+C Gram-positive bacteria) (Gey van Pittius 2001), 
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and have more recently been identified in firmicutes (low G+C Gram-positive bacteria) (Pallen 
2002) and chloroflexi (Sutcliffe 2011).  The recognized presence of ESX-type systems outside of 
mycobacteria led to the proposal that these systems be identified as a new, distinct class of 
alternative secretion systems, thereby deserving to be added to the conventional nomenclature of 
bacterial secretion systems.  Thus, ESX-type systems became termed “type VII secretion 
systems” (Abdallah 2007), although this nomenclature is not universally accepted.   
 
Conserved components of ESX-type secretion systems 
Two proteins are conserved among all ESX-type systems, a small EsxA-like protein and a 
predicted ATPase of the FtsK/SpoIIIE family (Pallen 2002).  The sequence homology between 
EsxA-like proteins is low, but these proteins all share some defining characteristics, including a 
size of approximately 100 amino acids, the presence of a WXG amino acid motif, a helical 
protein structure, and the lack of an N-terminal signal sequence.  These features led to the 
categorization of these proteins as “WXG100” family proteins (Pallen 2002).  The ESX-
associated FtsK/SpoIIIE family ATPases contain multiple (2-3) ATPase domains.  This is in 
contrast to canonical members of this protein family, which have a single ATPase domain.  In 
fact, among ATPases of the FtsK/SpoIIIE family, the presence of multiple enzymatic domains is 
found solely in ATPases encoded within ESX loci.  Thus, the close genetic proximity of a multi-
FtsK/SpoIIIE domain containing ATPase with a WXG100 protein-encoding gene serves as a 
genetic marker for ESX-type systems. 
 
While all ESX loci encode at least one WXG100 protein and an FtsK/SpoIIIE family ATPase, 
there is a large amount of variability in the additional genes that make up each locus, both in 
number and homology.  Many of the genes conserved among mycobacterial ESX loci are not 
present in other species.  Likewise, some genes are conserved solely among firmicutes and others 
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among actinobacteria.  Thus, it is unclear whether ESX-type systems share a conserved function 
and/or a conserved mechanism of action.  
 
FtsK/SpoIIIE family ATPases 
The ATPases associated with ESX loci are of the FtsK/SpoIIIE protein family.  ATPases of this 
family are conserved throughout bacteria and are predominately involved in the translocation of 
DNA and proteins through membrane-spanning pores (Iyer 2004).  FtsK/SpoIIIE proteins are 
important in the processes of cell division, sporulation and DNA conjugation, as well as others.  
The founding members of this family, FtsK of E. coli and SpoIIIE of B. subtilis, are responsible 
for the translocation of double stranded chromosomal DNA from the mother to the daughter cell 
compartment during cell division and sporulation, respectively.  FtsK coordinates chromosome 
segregation and chromosome dimer resolution during cell division to ensure the equal partitioning 
of genetic material between the mother and daughter cell (Begg 1995, Aussel 2002).  SpoIIIE is 
required for the segregation of chromosomal DNA from the mother cell to the prespore during the 
asymmetric cell division process of sporulation (Wu 1994).  FtsK and SpoIIIE achieve these 
functions by translocating along the DNA in an ATP-dependent manner, resulting in the pumping 
of DNA from one compartment to the other (Bath 2000, Aussel 2002). 
 
Clues to the molecular mechanism by which FtsK/SpoIIIE family ATPases couple ATP 
hydrolysis to substrate translocation first came from structural studies of AAA+ family ATPases.  
Many members of this superfamily, including RecA and DnaB, have been shown to function as 
oligomers, specifically hexamers (Iyer 2004).  Additional structural insight came from the crystal 
structure of the R388 plasmid-encoded DNA translocase TrwB.  TrwB, which is similar to 
FtsK/SpoIIIE family proteins, is essential for the transfer of single stranded DNA during bacterial 
conjugation (Gomis-Ruth 2001).  The crystal structure of TrwB revealed a homohexameric ring 
structure with a central channel large enough to accommodate a single strand of DNA, leading to 
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the hypothesis that ATP hydrolysis powers the translocation of a single DNA strand through the 
hexameric ring into the recipient cell during mating.  Structural data on FtsK followed and 
demonstrated that FtsK similarly forms ring-shaped hexamers with a central channel large enough 
to allow the passage of double stranded DNA (Massey 2006).   
 
Studies of non-mycobacterial ESX-type secretion systems 
It remains to be determined whether ESX-type secretion systems are part of a general virulence 
strategy of Gram-positive pathogens.  The ESX-type secretion systems of the pathogens 
Staphlococcus aureus, Bacillus anthracis, and Listeria monocytogenes are currently being 
investigated (Burts 2005, Garufi 2008, Way 2005).  While the S. aureus ESX-type system is 
required for the virulence of this pathogen in mouse models of infection, the L. monocytogenes 
system is not required for virulence.  Additionally, while the secretion of one or more EsxA-like 
proteins has been demonstrated in each system, there are differential requirements for the 
secretion of this substrate among species.  For example, the secretion of EsxA and EsxB in S. 
aureus is dependent upon the conserved FtsK/SpoIIIE family ATPase, but the ATPase of this 
family is dispensable for the secretion of B. anthracis EsxB.   
 
The function(s) ESX-type secretion systems in nonpathogenic bacteria is even more unclear.  To 
date, the ESX-type system of only one nonpathogenic bacterium, Streptomyces coelicolor, has 
been studied.  In this system, the secretion of an EsxAB heterodimer is dependent upon at least 
two genes within the locus, one of which is an FtsK/SpoIIIE family ATPase (Akpe San Roman 
2010).  Interestingly, the deletion of esxAB causes a sporulation defect resulting in spore chains 
with an abnormal wrinkled morphology, a phenotype that is reminiscent of the altered colony 
morphology associated with the loss of the ESX systems from mycobacteria. 
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Bacillus subtilis yuk operon 
B. subtilis is one of the most widely studied Gram-positive model organisms.  In addition to the 
ease in which this bacterium can be manipulated in the laboratory, there is a wealth of genetic and 
biochemical techniques and tools available that can be used to probe any number of biologic 
questions.  For these reasons, we have chosen to use B. subtilis to develop a tractable model 
system in which to study the function and mechanism of action of ESX-type secretion systems. 
 
A locus predicted to encode an ESX-type secretion system B. subtilis was recognized almost a 
decade ago (Pallen 2002), but this prediction has yet to be experimentally validated.  The B. 
subtilis yuk operon encodes for five genes:  yukE, yukD, yukC, yukBA, and yueB.  YukE is the 
predicted substrate of this potential system, as it is homologous to the Mtb EsxA protein.  YukBA 
is a predicted FtsK/SpoIIIE family ATPase with three ATPase domains.  The remaining genes of 
the yuk operon are not homologous to known ESX-associated proteins.  Bioinformatic analysis 
predicts yukD to encode a putative bacteriocin, but whether this prediction is functionally relevant 
is unknown (de Jong 2006).  YukC is a predicted membrane-associated protein of unknown 
function.  YueB is a surface-exposed, membrane-bound protein containing six transmembrane 
domains which has been shown to be essential for the irreversible binding of the bacteriophage 
SPP1 to the bacterium (São-José 2004).  
 
1.7 Dissertation aims 
 
It is currently unclear what commonalities exist between ESX-type secretion systems and whether 
these systems retain a conserved function in all species.  While all systems studied to date have 
been shown to be responsible for the secretion of an EsxA-like substrate, the functional 
consequences of this action are unknown.  This family of secretion systems was originally 
identified because of its role in Mtb virulence, but the conservation of ESX-type systems in 
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nonpathogenic bacterial species, and the finding that these systems are not universally required 
for the virulence of ESX-encoding pathogenic bacteria, suggests that these systems may play an 
important role in the bacterium itself.  Additionally, the conservation of an FtsK/SpoIIIE family 
ATPase with a domain structure unique to ESX-type systems suggests that these systems may 
share a common mechanism of action.  Thus, the continued study of ESX-type secretion systems 
in various bacterial species will provide insight as to how these secretion systems work, and with 
this knowledge we aim to gain understanding of the mechanism by which the ESX-1 system of 
Mtb mediates the virulence of this devastating human pathogen. 
 
In this dissertation, we aim to address questions of ESX function and mechanism by combining 
studies of the Mtb ESX-1 secretion system with the development of a tractable model system in 
the nonpathogenic bacterium B. subtilis.  Chapter 2 describes the development of the B. subtilis 
model to study the ESX-type secretion system of this bacterium, encoded for by the yuk operon.  
We begin to characterize this system by assessing the functions and genetic requirements of the 
yuk system.  In Chapter 3A, we determine the requirements for each ATPase domain of YukBA 
in powering yuk secretion.  Additionally, we use the B. subtilis model to dissect the mechanism of 
action of this unique class of motor proteins.  In Chapter 3B, we test the energy requirements for 
ESX-1-mediated secretion in Mtb.  Lastly, in Chapter 4, we determine the energy requirements 
for ESX-mediated cell wall functions in each system, allowing for a comparison of the ATPase 
requirements for secretion and cell wall interactions of both the Mtb and B. subtilis ESX-type 
systems. 
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CHAPTER 2: Characterization of the Bacillus subtilis ESX-type yuk 
secretion system 
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2.1 Introduction 
 
The ability to transport proteins, DNA, lipids and small molecules across the hydrophobic barrier 
created by the cell membrane is essential to the survival of every bacterium.  Central to this 
process are bacterial secretion systems, which direct the substrate translocation required for a 
diverse array of processes, from maintaining homeostasis to mediating virulence.  In addition to 
the general secretory pathway, mediated by the Sec system, and the folded protein secretion 
pathway, mediated by the TAT system, bacteria have evolved alternative secretion systems to 
mediate the secretion of dedicated subsets of substrates.  These specialized systems are often 
nonessential, but can be required for bacterial growth or survival under certain conditions.  To 
date, six classes of specialized secretion systems, designated type I-type VI, have been identified 
and characterized in Gram-negative bacteria.  More recently, a novel class of secretion systems 
unique to Gram-positive bacteria was identified, and later termed type VII secretion systems 
(Abdallah 2007).  The first of these alternative secretion systems was identified in the human 
pathogen Mycobacterium tuberculosis (Mtb).   
 
This secretion system, designated the ESX-1 secretion system, is a critical mediator of Mtb 
virulence; loss of this system significantly attenuates the bacterium in vivo (Stanley 2003, Guinn 
2004).  Despite the importance of this system, the mechanism by which ESX-1 mediates 
virulence is not clearly understood.  ESX-1 has been hypothesized to mediate virulence through 
the secretion of protein effectors that act on specific targets in the macrophage.  To date, six 
secreted substrates have been identified, including the first identified protein antigens EsxA and 
EsxB, as well as EspA, EspB, EspC and EspR (Sorenson 1995, Berthet 1998, Fortune 2005, 
MacGurn 2005, Xu 2007, McLaughlin 2007, Raghavan 2008).  While EsxA is thought to act as a 
pore-forming toxin, the function of most of these secreted proteins remains unknown (Hsu 2003, 
de Jonge 2007).  More recently, it has been demonstrated that ESX-1-mediated virulence is 
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independent of protein secretion, and virulence is dependent upon ESX-1-mediated maintenance 
of cell wall integrity (Garces 2010).   
 
Many questions remain to be answered about the functions and mechanism of the ESX-1 
secretion system and ESX-type secretion systems more generally.  However, the many inherent 
challenges of working with Mtb often limit the questions that can be posed.   Using in silico 
methods to search for esxA-like genes, ESX-type secretion systems have been identified 
throughout Gram-positive bacterial species, including various actinobacteria (high G+C Gram-
positive bacteria) (Gey van Pittius 2001, Pallen 2002), firmicutes (low G+C Gram-positive 
bacteria) (Pallen 2002), and chloroflexi (Sutcliffe 2011).  Within ESX-loci, the genes encoding an 
esxA-like substrate protein and an FtsK/SpoIIIE family ATPase are conserved across all species.  
The conservation of these key components of the secretion system suggests a conserved 
mechanism of action.  This provides an opportunity to use model bacterial systems to gain insight 
into how these secretion systems work.  While the ESX-type secretion systems of other human 
pathogens including Staphlococcus aureus, Bacillus anthracis, and Listeria monocytogenes are 
currently being investigated, we sought to develop a tractable model system using the 
nonpathogenic, soil-dwelling bacterium Bacillus subtilis (B. subtilis).  This easily manipulated 
model organism provides a wealth of experimental tools and biologic understanding which we 
can use to parse the structure and function of this family of secretion systems.   
 
It has been bioinformatically predicted that the B. subtilis yuk operon may encode an ESX-type 
protein secretion system (Pallen 2002).  The yuk operon encodes five genes, yukE, yukD, yukC, 
yukBA, and yueB, which are thought to be under the control of a single promoter (Figure 2-1A).  
YukE is a small, WXG100-motif containing protein homologous to the secreted substrate EsxA 
of Mtb, and YukBA is homologous to the ESX-1-encoded FtsK/SpoIIIE-like ATPases EccCa-
EccCb.  The remaining genes of the yuk operon are not homologous to known ESX-associated 
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proteins.  YukD is predicted to encode a small polypeptide, and one study identified yukD as a 
putative bacteriocin-encoding gene by bioinformatic analysis, but this prediction has not been 
addressed experimentally (de Jong 2006).  YukC is predicted to be a single-pass transmembrane 
protein of unknown function.  YueB is a transmembrane protein with six transmembrane 
segments, and studies have demonstrated that YueB is a phage receptor for the SPP1 
bacteriophage (São-José 2004).  It is common for phage to utilize exposed protein domains as 
docking sites, thus, it is likely that YueB has an additional function(s) that is independent of its 
role as a phage receptor.   
 
In this study, we demonstrate that the yuk operon encodes a secretion system responsible for the 
secretion of the EsxA homologue, YukE.  Additionally, we find that the yuk system plays a role 
in biofilm formation in a manner that is independent of YukE secretion.   
 
2.2 Results 
 
YukE is secreted by B. subtilis 
All ESX-type secretion systems that have been studied to date have been shown to secrete at least 
one protein homologous to the prototypic ESX-1 substrate EsxA.  In B. subtilis, this protein is 
encoded for by yukE.  Therefore, we first tested whether YukE is secreted into the culture 
supernatant of B. subtilis as predicted.  Wild-type cultures of the B. subtilis laboratory strain 
PY79 were grown in rich culture media to mid-exponential phase, at which time whole cell pellet 
and culture supernatant were collected for analysis.  Proteins were separated on an SDS-PAGE 
gel and assayed for YukE secretion by immunoblot using an antibody generated against full 
length YukE.  YukE was detected in the pellet and supernatant of wild-type B. subtilis, but absent 
from a ∆yukE strain (Figure 2-1B). 
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Genetic requirements for YukE secretion 
If the genes of the yuk locus encode proteins that come together to form a secretion system, then 
the loss of any gene in the locus should abolish protein secretion.  Indeed, in all ESX-type 
systems that have been assessed, secretion of the EsxA-like substrate is dependent upon at least 
some genes encoded within the surrounding genetic locus (Stanley 2003, Guinn 2004, Burts 
2005, Garufi 2008, Akpe San Roman 2010).  To test the genetic requirements for YukE secretion, 
we created individual deletion mutants in which we replaced each of the yuk genes with an 
antibiotic resistance cassette via double crossover recombination, generating ∆yukD, ∆yukC, 
∆yukBA and ∆yueB.  Because the yuk genes are organized in an operon, we reinserted the yuk 
promoter (Pyuk) after the antibiotic resistance cassette in each knockout strain to drive expression 
of the remaining downstream operon genes (diagrammed in Figure 2-1A).  We verified that 
deletions within the yuk locus do not result in a growth defect or loss of fitness through growth 
curves and competition experiments (data not shown, Supplemental Figure 2-1).   
 
To determine whether the genes of the yuk operon are required for YukE secretion, we tested the 
expression and secretion of YukE in each deletion mutant.  While YukE is present in the pellet of 
each deletion strain, YukE was not detected in the culture supernatants of any of the four mutant 
strains (Figure2-1B).  To demonstrate the specificity of these results, a complementing construct 
containing a myc-tagged copy of the corresponding gene, fused to an inducible promoter, was 
inserted at an ectopic chromosomal locus in each knockout strain.  The expression of each 
construct was verified by immunoblot with an anti-Myc antibody (data not shown).  As seen in 
Figure 2-1B, YukE secretion was fully restored in the ∆yukD and ∆yukBA strains upon expression 
of yukD-myc and yukBA-myc, respectively.  Although complementation of ∆yukC with yukC-myc 
and ∆yueB with yueB-yueC-myc did not complement YukE secretion to wild-type levels, a 
restoration of YukE secretion can be seen in an overexposed immunoblot.  Together, these data 
demonstrate that YukE secretion is dependent upon each gene within the yuk operon and this 
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supports the hypothesis that the yuk locus encodes a functional secretion system responsible for 
the secretion of YukE. 
 
              
 
Figure 2-1.  B. subtilis yuk locus and genetic requirements for YukE secretion. 
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Figure 2-1 (continued).  (A). Schematic depicting the native yuk locus (white background) and 
yuk deletion strains used in this study (shaded background).  The predicted promoter of the yuk 
operon (yukE-yueB) is indicated with a black arrow and the predicted terminator is indicated with 
a black circle.  For each deletion strain, a yuk gene was replaced with an antibiotic resistance 
cassette (erm); the yuk promoter (black arrow) was inserted after the antibiotic resistance cassette 
to drive expression of the remaining downstream operon genes.  (B). Immunoblot analysis of cell 
pellet (P) and culture supernatant (S) of wild-type, yuk deletion, and corresponding 
complemented strains.  Samples from cultures grown in LB media were separated by SDS-PAGE 
under reducing conditions and analyzed by immunoblot with an α-YukE antibody.  A ∆yukE 
strain demonstrates antibody specificity.  An antibody to SigmaA was used as a lysis and loading 
control. Asterisk (*) in far right-hand lane indicates overloading of sample 1.5x that of all other 
lanes.  The α-YukE supernatant blot is shown in two exposures; overexposed blot allows 
visualization of faint bands.  Data are representative of at least three independent experiments. 
 
The yuk operon is upregulated under nutrient poor growth conditions 
The function(s) of ESX-type secretion systems in nonpathogenic bacteria is not known.  To begin 
to address this question, we first sought to determine under which growth conditions the yuk 
operon is expressed.  To follow expression from the yuk promoter (Pyuk), we created two lacZ 
transcriptional fusion reporter strains in wild-type B. subtilis.  This reporter allows us to assay the 
level of expression from the yuk promoter through colorometric β-galactosidase (β-gal) assays.  
In one strain, the lacZ reporter gene was integrated at the endogenous start site of the yuk operon 
(ΩPyuk-lacZ).  In a second strain, we integrated a Pyuk-lacZ construct at an ectopic integration 
site (amyE::Pyuk-lacZ).   
 
To test whether yuk expression varies in response to nutrient availability, we compared the 
expression of lacZ in nutrient rich media (LB) versus defined, nutrient poor media (MC).  As seen 
in Figure 2-2, expression from the yuk promoter is 2-fold higher in defined media as compared to 
nutrient rich media.  These results suggest that the yuk operon may be important for a bacterial 
response triggered by nutrient deprivation. 
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Figure 2-2.  The yuk operon is upregulated in minimal media. 
Expression from the yuk promoter (Pyuk) was measured using Pyuk-lacZ transcriptional fusions; 
promoter activity was monitored by quantitative β-galactosidase assays.  The Pyuk-lacZ reporter 
was integrated at the start of the endogenous yuk operon (ΩPyuk-lacZ) and at an ectopic 
integration site (amyE::Pyuk-lacZ).  Strains were grown in rich media (LB) or minimal media 
(MC).  Data are representative of three independent experiments.  AU:  abritrary units. 
 
YukE is the dominant dedicated substrate of the yuk secretion system 
To gain insight into possible function(s) of the yuk system, we sought to determine whether there 
are additional secreted proteins dependent upon the yuk system for secretion.  In some ESX-type 
systems, substrates have been identified which are not linked to the primary genetic locus 
encoding for the secretion system (Fortune 2005, Garufi 2008).  Therefore, we sought to globally 
identify potential yuk substrates by using a quantitative proteomics approach to compare the 
proteins secreted by a wild-type strain versus a strain lacking a functional yuk secretion system.  
Using quantitative mass spectrometry, we compared the culture supernatants of wild-type, 
∆yukBA, and ∆yukBA, p-yukBA-myc strains grown in minimal media, as this growth condition 
was suggested to be functionally relevant based on the upregulation of yuk expression.  As 
predicted from our immunoblot analysis, we detected abundant YukE in the culture supernatants 
of the wild-type laboratory strain; furthermore, YukE was secreted in a yukBA-dependent manner 
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(Figure 2-3).  Interestingly, no other proteins were identified that fit the profile of a potential yuk 
substrate; present in wild-type culture supernatants, absent in ∆yukBA, and restored upon 
complementation.  These data suggest that YukE is the dominant dedicated substrate of the yuk 
secretion system, though we cannot rule out the possibility that there are other substrates of this 
system which are secreted under different growth conditions.  
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Figure 2-3.  YukE is the only protein whose secretion is solely dependent upon YukBA. 
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Figure 2-3 (continued).  (A). Number of YukE-specific peptide spectra detected in the culture 
supernatants of the indicated strains.  (B). and (C). The relative abundance of proteins in the 
culture supernatants from wild-type compared to ∆yukBA (B) or the complemented strain 
∆yukBA, p-yukBA-myc (C) grown in minimal media.  Each point corresponds to a specific B. 
subtilis protein.  Protein abundance was determined by spectral count analysis; spectral count data 
are combined totals from three biologically independent samples for each strain.  Where no 
spectra were identified, an arbitrary value of 1 was assigned.  Red diamonds indicate YukE; 
change in YueB abundance is a result of the method used to construct the ∆yukBA and ∆yukBA, 
p-yukBA-myc strains.   
 
The yuk operon is actively expressed in the undomesticated strain B. subtilis 3610 
We have found that the yuk operon is more highly expressed under nutrient limiting growth 
conditions as compared to nutrient rich conditions.  Nutrient depletion is known to trigger a 
variety of highly regulated responses by B. subtilis, such as entrance into stationary phase, 
induction of sporulation, and biofilm formation.  Thus, the upregulation of Pyuk in minimal 
media may represent a role for the yuk system in one of these processes.   
 
We did not find the yuk deletion strains to have defects in stationary phase growth or gross 
sporulation defects, as compared to a wild-type strain (data not shown).  We next tested whether 
the yuk operon plays a role in biofilm formation.  B. subtilis can respond to stress by forming 
highly complex, 3-dimensional, multicellular communities known as biofilms.  While laboratory 
adapted B. subtilis strains, such as PY79, can form biofilms, undomesticated B. subtilis strains 
can form particularly robust and elaborate biofilm structures (Branda 2001).  To address whether 
the yuk secretion system plays a role in biofilm formation, we first sought to test the level of yuk 
expression in the undomesticated strain B. subtilis 3610.  To do so, we integrated the Pyuk-lacZ 
reporter construct into a wild-type 3610 strain, both at the endogenous yuk locus (3610, ΩPyuk-
lacZ) and at an ectopic integration site (3610, amyE::Pyuk-lacZ).  We find the yuk promoter to be 
more highly expressed in the 3610 strain as compared to the PY79 laboratory adapted strain, with 
levels of expression 2-3 fold higher (Figure 2-4).  Additionally, in the 3610 strain, Pyuk is 
upregulated in minimal media as compared to rich media. 
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These results demonstrate that the yuk operon is expressed in the undomesticated 3610 strain, but 
the above experiments were performed using bacterial cultures grown in liquid media under 
standard shaking culture conditions.  To test whether the yuk operon is actively expressed under 
biofilm-inducing conditions, we spotted the 3610 Pyuk-lacZ reporter strain on solid biofilm-
inducing MSgg media also containing the colormetric substrate X-gal (Branda 2001).  We find 
the yuk promoter to be expressed within the biofilm, with the most active expression seen around 
the central ring of the biofilm and in the actively-dividing cells around the perimeter (Figure 2-4).  
Thus, the yuk operon is expressed in B. subtilis 3610 under both standard laboratory and biofilm-
inducing growth conditions. 
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Figure 2-4.  Expression from the yuk promoter in the undomesticated strain B. subtilis 3610. 
(A). Expression from the yuk promoter (Pyuk) was measured using Pyuk-lacZ transcriptional 
fusions integrated into the wild-type undomesticated B. subtilis 3610 strain.  The Pyuk-lacZ 
reporter was integrated at the start of the endogenous yuk operon (ΩPyuk-lacZ) and at an ectopic 
integration site (amyE::Pyuk-lacZ).  Strains were grown in broth culture with rich media (LB) or 
minimal media (MC); promoter activity was monitored by quantitative β-galactosidase assays.  
Data are representative of three independent experiments.  AU: arbitrary units.  (B). A B. subtilis 
3610 strain containing an integrated Pyuk-lacZ reporter (amyE::Pyuk-lacZ) was grown on MSgg 
agar to induce biofilm formation.  Media contained X-gal to allow for visualization of yuk 
expression (blue color).  Left panel: entire biofilm; right panel: close up view of biofilm center.  
Scale bar: 0.5 cm, indicated for each view. 
 
Normal biofilm architecture is dependent upon YukBA 
To investigate the functional consequences of disrupting the yuk system on biofilm formation, we 
created ∆yukE, ∆yukD, ∆yukC, and ∆yukBA deletion strains in the 3610 background.  Each strain 
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was then plated on solid, biofilm-inducing media and the resulting biofilms were compared to a 
biofilm produced by wild-type 3610.  Knocking out yukE, yukD, or yukC did not alter the 
appearance of the biofilm as compared to wild-type 3610 (Figure 2-5).  Interestingly, biofilms 
formed by the ∆yukBA strain had an altered morphology as compared to wild-type; this defect is 
most pronounced in the center of the biofilm.  The expression of a yukBA complementing 
construct restored the biofilm to an appearance similar to that of wild-type.  These results suggest 
a biofilm-specific function for the yuk secretion system that is independent of YukE secretion.  
Biofilm formation may require the secretion of an additional yet-to-be identified substrate, or the 
role of the yuk system may be secretion independent. 
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Figure 2-5.  Loss of yukBA, but not yukE, results in a defect in biofilm formation. 
B. subtilis 3610 wild-type and yuk knockout strains were grown on MSgg agar to induce biofilm 
formation.   As diagrammed in the bottom image, left panels: entire biofilm; right panels: close up 
view of biofilm center.  Scale bar: 0.5 cm, indicated for each view. 
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2.3 Discussion 
 
We have developed a model system in which to study the function and mechanism of the ESX-
type yuk secretion system of B. subtilis.  We have demonstrated that YukE is a secreted protein, 
as predicted by its homology to the secreted virulence factor EsxA of Mtb.  YukE secretion is 
dependent upon each of the four other proteins encoded within the yuk operon, and we have 
found YukE to be the only dedicated substrate of this secretion system.  These results suggest that 
the yuk operon encodes a bona fide ESX-type secretion system.   
 
ESX-type secretion systems are conserved throughout pathogenic and nonpathogenic species.  It 
is currently unclear what the primary function of these systems is and whether ESX-type 
secretion systems share a conserved function(s).  All ESX-type systems studied to date have been 
shown to be responsible for the secretion of a conserved EsxA-like protein substrate, but these 
proteins do not have an obvious effector function, and it is unclear how the secretion of a single 
conserved substrate could be beneficial to bacterial species representing such a wide range of 
lifestyles and environmental niches. 
 
Studies of the ESX-1 system of Mtb have demonstrated that this system mediates virulence not 
through the secretion of the known ESX-1 protein substrates, but rather virulence is dependent 
upon a not yet understood role of ESX-1 in maintaining bacterial cell wall integrity (Garces 
2010).  Interestingly, we have found that the yuk secretion system is also important in a 
fundamental aspect of B. subtilis biology, the formation of biofilms.  In the absence of the 
ATPase YukBA, biofilm architecture of the undomesticated B. subtilis 3610 strain is altered.  
This defect is particularly apparent in the center region of the biofilm.  The central ring of the 
biofilm is also the area we found to most highly express the yuk operon, suggesting that the yuk 
system may be required for a function specific to cells in this region of the biofilm community.  
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The requirement for the yuk system in biofilm formation is independent of YukE secretion.  It is 
possible that the yuk secretion system secretes additional substrate(s) required for this process, 
and that these substrates are only secreted under biofilm-inducing conditions and thus were not 
identified in our proteomic analysis of B. subtilis supernatants.  Alternatively, the yuk system may 
play a role in biofilm formation that is independent of protein secretion.  Together, these results 
suggest that in addition to being responsible for the secretion of EsxA-like substrates, ESX-type 
secretion systems may share a conserved function in modulating the bacterial cell wall.   
 
2.4 Materials and Methods 
 
Culture of B. subtilis and preparation of whole cell pellets and culture supernatants 
All B. subtilis strains were derived from the prototrophic strain PY79 (Youngman 1983) or, 
where indicated, the undomesticated strain 3610 (Branda 2001).  Strains were maintained in 
Miller LB broth (Acros, New Jersey, USA) or on Difco Miller LB agar (BD, Sparks, MD).  When 
appropriate, antibiotics were included in the growth media as follows: 100 μg/mL spectinomycin, 
5 μg/mL chloramphenicol, 5 μg/mL kanamycin, 10 μg/mL tetracycline, and 1 μg/mL 
erythromycin plus 25 μg/mL lincomycin (mls).  Where indicated, strains were grown in the 
defined media B. subtilis Medium for Competence (MC) (Cutting 1990). 
 
For analysis of protein expression and secretion, mid-log bacterial cultures started from a single 
colony were back diluted and normalized to an OD600 of 0.02 in LB media and grown 2 hours at 
37
oC, at which time 100 μM IPTG (isopropyl-β-D-thiogalactopyranoside) was added to induce 
protein expression.  Cultures were grown an additional 2 hours.  Cell pellets were collected by 
centrifugation at 4,000 rpm for 20 minutes and resuspended in lysis buffer (20 mM Tris∙HCl pH 
7.5, 10 mM EDTA, 1 mM PMSF, 10 μg/ml DNase I, 100 μg/ml RNaseA, 1 mg/mL lysozyme) 
and incubated at 37
o
C for 10 minutes.  SDS sample buffer (Novex 2x Tricine SDS sample buffer, 
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Invitrogen) was added and samples were heated to 95
o
C for 15 minutes.  Culture supernatants 
were filtered though a 0.2 μM filter to remove unlysed cells.  Following the addition of a protease 
inhibitor cocktail (Complete Mini, EDTA-free tablets, Roche, Mannheim, Germany) the 
supernatants were concentrated by precipitation with 10% tricholoric acid (TCA), resuspended in 
SDS sample buffer and heated to 95
o
C for 15 minutes. 
 
Strain construction 
General methods for molecular cloning and strain construction were performed according to 
published protocols (Sambrook 2006).  Schematic of yuk deletion mutants can be seen in Figure 
2-1.  Where indicated, the yuk promoter was inserted downstream of the knockout construct to 
drive expression of downstream operon genes.  As the yuk promoter has not been previously 
characterized, we used the 417 base-pair sequence directly upstream of yukE.  We confirmed that 
this promoter sequence was transcriptionally active by testing its ability to drive the expression of 
a Pyuk-lacZ reporter construct integrated at an ectopic chromosomal locus (amyE::Pyuk-lacZ).  
Chromosomal DNA isolated from the prototrophic laboratory strain PY79 was used as a template 
for all PCR amplification.  All constructs were first introduced into PY79 by transformation 
(Gryczan 1978) and then transferred to the 3610 background using SPP1-mediated generalized 
phage transduction (Yasbin 1974).  The bacterial strains used in this study are listed in 
Supplemental Table 2-1. 
 
Generation of complementing constructs 
To generate complementing constructs, the gene of interest was amplified by PCR with primers 
designed to add amyE front and amyE back sequences for chromosomal integration, as well as 
restriction sites for cloning.  The reverse oligo also added a C-terminal Myc-tag (protein 
sequence: MAEQKLISEEDLA) yukD, yukC, yukBA and yueC complementing constructs; yukE 
and yueB remained untagged.  Amplified sequences were cloned by restriction digest into the 
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integrating plasmid pamyE::Phyperspank, which contains an IPTG-inducible Phyperspank promoter 
(a gift from David Rudner).  This plasmid was integrated into PY79 by double crossover 
recombination, resulting in the integration of the plasmid at the amyE locus in the B. subtilis 
chromosome.  All constructs were confirmed by sequencing. 
 
YukE polyclonal antibody generation 
A histidine-tagged verison of full-length YukE was utilized for antibody production.  yukE was 
PCR-amplified using genomic DNA from the wild-type laboratory strain PY79 as a template.  
The sequence was inserted into an inducible E.coli expression vector and transformed into E. coli 
BL21 cells.  YukE-HIS was purified from E .coli extracts by affinity chromatography.  A rabbit 
polyclonal serum was raised against this protein (Covance). 
 
SDS-PAGE and immunoblot analysis 
Prior to analysis, samples were reduced with 100 mM dithiothreitol (DTT) for 1 hour at 37
o
C.  
Proteins were separated by SDS-PAGE and transferred to a nitrocellulose membrane (Bio-Rad) 
for immunoblot analysis.  Membranes were probed with anti-YukE (1:1,000) and anti-Myc 
(1:3,000, ab9106, Abcam, Cambridge, MA).  A peroxidase-conjugated goat anti-rabbit secondary 
antibody (1:3,000, ab6721, Abcam, Cambridge, MA) was detected by chemiluminescence using 
SuperSignal West Femto (Thermo Scientific).  An antibody to the abundant cytosolic protein 
SigmaA was used to ensure equal protein loading and as a lysis control (1:1,000,000, Fujita 
2000).  Blots were imaged using a FluorChem FC2 gel documentation system (Alpha Innotech) 
and provided software.   
 
Mass spectrometry  
Bacterial strains were grown in MC media to an OD600 of ~2.0. The cells were pelleted and the 
supernatant was removed to a new conical and filtered through a 0.2 μM filter. Total proteins in 
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the supernatant were obtained by TCA precipitating 30 mL of sample as described above. The 
samples were prepared for mass spectrometry analysis as described previously (Garces 2010). 
Briefly, samples were fractionated by molecular weight on a 10-20% Tricine gel (Invitrogen), 
followed by in-gel reduction, akylation and trypsin digestion. Samples were run on a Thermo 
Fisher Scientific LTQ Veloz Mass Spectrometer (Thermo Fisher Scientific, Cambridge, MA). 
Samples were injected onto a Proxeon Easy nLC system configured with a 5 cm x 100 µm trap 
packed with 15-20 µm PS-DVB 300A media, and a 25 cm x 100 µm ID resolving column packed 
with 200A C18AQ media. Buffer A was 96% water, 4% methanol, and 0.2% formic acid. Buffer 
B was 10 % water, 10% isopropanol, 80% acetonitrile, and 0.2% formic acid; loading buffer 
(sample loading/rinsing buffer) was 96% water, 4% methanol, and 0.2% formic acid. Samples 
were loaded at 5 µL a min for 9 min, and a gradient from 0-60% B at 375 nl/min was run over 70 
min, for a total run time of 115 min (including regeneration and sample loading). Injection 
standards (Michrom Medium Molecule test mix, 5 angios, and the TP4 peptides) were injected at 
61 fmoles per sample. Velos was run in a data dependent 15 configuration, with a full scan run in 
the in enhance scan mode (3
e
4 target), with up to 15MS2 events. Rejection of +1 ions was used in 
precursor ion selection.  
 
Resulting spectra were searched against a composite database which contained the predicted open 
reading frames annotated in the genome of Bacillus subtilis 168 supplemented with common 
contaminates using SEQUEST (Thermo Scientific, San Jose, CA). Peptides were filtered at a 1% 
FDR with PeptideProphet and grouped into proteins with ProteinProphet (Keller 2005) with a 
cutoff of 0.95. Spectral counts across the gel slices for three biological replicates were pooled, 
and then levels of protein expression between strains were compared using an extended G-test 
(Zhang 2006). Data was corrected for multiple testing (Benjamini and Hochberg) using a p value 
of ≤0.01; for a given protein, a criterion of having ≥ 5 peptides in at least one strain was set. 
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β-galactosidase assays 
β-galactosidase assays were performed as previously described (Camp 2009).  Briefly, bacterial 
strains were grown in the specified media at 37
o
C.  1 mL of cells were harvested at the given time 
point and the OD600 was recorded.  Cell pellets were resuspended in 0.5 mL Z buffer (40 mM 
NaH2PO4, 60 mM Na2HPO4, 1 mM MgSO4, 10 mM KCl, 38 mM β-mercaptoethanol) 
supplemented with 0.2 mg/ml lysozyme in a clear well 96-well plate.  After incubation for 20 
minutes at 37°C, reactions were started by adding 50 μL of 4 mg/mL ONPG (2-nitrophenyl β-D-
galactopyranoside) (Sigma-Aldrich).  The OD420 values of the samples were recorded once per 
minute for sixty minutes at 37°C in a Synergy 2 plate reader (BioTek).  β-galactosidase activity 
corresponds to the rate of ONPG conversion, and it is calculated as follows:  arbitrary units (AU) 
= [slope of OD420 * dilution factor]/[OD600 of harvested cells].   
 
Assays of biofilm and pellicle formation 
For colony architecture analysis on solid media, a fresh colony was resuspended in 30 μL of PBS; 
2 μL was spotted onto an MSgg plate with 1.5% Bacto agar (Branda 2001) and incubated at 30°C 
for 3 days.  Biofilms were imaged using a Leica Wild M10 camera with a Planapo 0,63x 
objective.   
 
Competition assay 
A wild-type strain containing an inducible lacZ reporter was co-cultured with one of the yuk 
deletion strains in either LB or MC media (starter culture).  The culture was placed rolling at 
22°C for 24 hours and the OD600 was recorded.  Mixed populations were created with the 
desired starting ratio of mutant:wild-type strain.  The mixed population was diluted 1:1000 to 
start a new 5 mL culture; culture was placed rolling at 22°C for 24 hours.  The following day, 
dilutions of the mixed population were plated in triplicate onto LB plates supplemented with 
IPTG (1 mM) and X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside, 0.02% wt/vol) and 
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placed at 37°C for 12-15 hours.  The wild-type blue colonies and mutant white colonies were 
counted and the numbers were recorded.  Every 24 hours, the culture was used to inoculate a new 
culture (1:1000 dilution) and was plated for colony counts.  This 24-hour process was repeated 
until the ratio of wild-type to mutant strain stabilized. 
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2.5 Supplementary Materials 
 
Supplemental Figure 2-1.  yuk deletion strains do not have a competitive growth defect as 
compared to the wild-type strain. 
 (A). and (B). To assess the fitness of each strain, ∆yukEDCBA (A) and ∆yukBA (B) deletion 
strains were grown in competition with a wild-type PY79 strain containing an inducible lacZ 
reporter.  Cultures were started at a ratio of 10% mutant to 90% wild-type cells.  On the indicated 
day, the percentage of each strain within a culture was determined by plating on LB plates 
supplemented with IPTG and X-gal and counting the resulting blue (wild-type) and white 
(mutant) colonies.  Shown are the mean percentages averaged from triplicate platings for each 
day.  
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Strain GenotypeA Source/Reference 
PY79 Prototrophic domesticated laboratory strain Youngman 1983
3610 Undomesticated wild strain Branda 2001
bLH015 yukE::erm-Pyuk This Chapter
bLH018 yukEDCBA::erm-Pyuk This Chapter
bLH019 amyE::Pyuk-lacZ This Chapter
bLH021 ΩPyuk-lacZ This Chapter
bLH109 yueB::erm This Chapter
bLH110 yukBA::erm-Pyuk This Chapter
bLH274 3610 yukE::erm-Pyuk This Chapter
bLH278 3610 yukBA::erm-Pyuk This Chapter
bLH285 3610 amyE::Pyuk-lacZ This Chapter
bLH286 3610 ΩPyuk-lacZ This Chapter
bLH288 3610 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-myc This Chapter
bLH404 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-myc This Chapter
bLH421 yukD::erm-Pyuk This Chapter
bLH422 yukC::erm-Pyuk This Chapter
bLH458 yukD::erm-Pyuk, amyE::Phyperspank-yukD-myc This Chapter
bLH497 3610 yueB::erm This Chapter
bLH500 yukC::erm-Pyuk, amyE::Phyperspank-yukC-myc This Chapter
bLH505 3610 yukD::erm-Pyuk This Chapter
bLH506 3610 yukC::erm-Pyuk This Chapter
bLH510 3610 yukD::erm-Pyuk, amyE::Phyperspank-yukD-myc This Chapter
bLH511 3610 yukC::erm-Pyuk, amyE::Phyperspank-yukC-myc This Chapter
bLH532 yueB::erm, amyE::Phyperspank-yueB-yueC-myc This Chapter
bLH533 yukE::erm-Pyuk, amyE::Phyperspank-yukE This Chapter  
 
Supplemental Table 2-1.  Strains used in this study. 
A 
All strains are isogenic with the B. subtilis laboratory wild-type strain PY79 unless otherwise 
indicated; “3610” indicates that the strain is isogenic with the B. subtilis undomesticated wild-
type strain 3610. 
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Chapter 3: Powering ESX secretion 
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Chapter 3A: The B. subtilis ATPase YukBA requires rotational 
symmetry among enzymatic domains for function  
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3A.1 Introduction 
 
AAA+ family ATPases are molecular machines which couple the energy derived from ATP 
hydrolysis to perform diverse functions within the cell, including the assembly, operation, or 
disassembly of protein complexes, protein unfolding and degradation, and the translocation and 
secretion of macromolecules (Neuwald 1999, Ogura 2001, Maurizi 2001).  The AAA+ ATPase 
domain is highly conserved from eukaryotes to prokaryotes, despite the wide range of functions 
performed by enzymes of this superfamily.  The structure of many AAA+ proteins has been 
solved, revealing a strong preference for these proteins to complex as a hexameric ring (Neuwald 
1999, Ogura 2001).  However, we have a limited understanding of the mechanism by which these 
protein complexes couple ATP hydrolysis to the mechanical movement of substrates.  Thus, it is 
not yet clear whether each AAA+ protein has a unique mechanical mechanism by which ATP 
hydrolysis powers work or whether general rules apply.    
 
Despite their common hexameric form, the manner in which the individual ATPase subunits of 
these enzymes assemble and coordinate nucleotide hydrolysis varies.  The composition of a 
hexameric machine can either be homeogenous, formed by six identical protein subunits, or 
heterogenous, where nonidentical proteins come together to form a hexamer.  In some 
homohexameric enzymes, ATP is symmetrically bound to each enzymatic subunit.  This is often 
suggestive of a concerted mechanism of ATP firing, in which all six subunits bind and hydrolyze 
ATP simultaneously (Gai 2004).  Alternatively, for some homohexamers, only a subset of the six 
potential active sites can bind nucleotide simultaneously.  Upon binding, these subunits undergo a 
conformational change, which generates structural asymmetry within the enzyme.  While each 
subunit within the hexamer is biochemically equivalent in its ability to bind and hydrolyze ATP, 
this conformational asymmetry dictates the pattern of active site firing within the ring.  Structural 
asymmetry often correlates with mechanistic models involving asynchronous patterns of ATP 
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firing.  These include a sequential model, in which individual subunits hydrolyse ATP in turn 
around the hexameric ring, and a probabilistic model, where individual subunits fire 
independently and in a random order (Martin 2005).  The heterogeneous subunit composition of 
heterohexameric enzymes allows for the evolution of subunit specialization, where active sites 
can perform nonidentical functions.  Additionally, subunits can be differentially required for 
enzyme function, serving active, regulatory, or structural roles.  The ability to identify the correct 
mode of action for a particular ATPase is central to uncovering how the AAA+ machine uses 
ATP hydrolysis to complete the task at hand. 
 
The mechanism of ATP firing for a given enzyme is typically determined by testing the 
functional consequences of mixing active and inactive subunits in varying ratios.  However, for a 
homohexameric enzyme, the results from such experiments are often difficult to interpret, as this 
approach does not fix the arrangement or relative contributions of active and inactive subunits 
within the hexamer.  To overcome this obstacle, investigators have used a strategy of covalently 
linking some or all of the subunits within a hexamer to create covalent multimers (Martin 2005, 
Crozat 2010).  Inactive subunits can be introduced into these multimers in defined geometric 
arrangements to determine the biochemical and spatial requirements for enzyme function. 
 
Missing from these mechanistic studies are the molecular motors responsible for protein secretion 
from bacterial cells.  One interesting group of proteins in which to study the mechanics of 
ATPase activity are the ATPases of ESX-type secretion systems of Gram-positive bacteria, also 
known as type VII secretion systems (Abdallah 2007).  ESX-type secretion systems are found 
throughout actinobacteria, firmicutes and chloroflexi, but the best studied is the ESX-1 system of 
Mycobacterium tuberculosis (Mtb), as this secretion system is required for the virulence of this 
clinically relevant human pathogen (Gey van Pittus 2001, Pallen 2002, Stanley 2003, Guinn 
2004).  Interestingly, the ATPases of ESX systems have a domain structure unique to this class of 
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proteins, where each protein contains two or three ATPase domains.  This is reminiscent of the 
linked subunit studies described above, thereby creating a unique opportunity to study the 
mechanism of these ATPases using a natural linked subunit model.  By understanding the 
functional consequences of inactivating subunits in a variety of geometric arrangements we can 
better understand the mechanism by which ESX-associated ATPases use ATP hydrolysis to 
power protein translocation.   
 
To address more detailed mechanistic questions about the function and mechanism of action of 
ESX-associated ATPases, we have developed a model system using the ESX-type secretion 
system of Bacillus subtilis (B. subtilis).  We leverage the B. subtilis model to assess complex 
formation and domain requirements of the ESX-associated ATPase, YukBA.  While the majority 
of studies addressing the molecular mechanisms of ATPases have used truncated, purified protein 
subunits to reconstitute hexameric complexes in vitro, we test the ATPase requirements of native 
YukBA.  Therefore, each enzymatic domain of YukBA is in a fixed orientation not only in 
relation to the other domains within a complex, but also relative to the cell membrane and other 
components of the secretion apparatus.  In this system, we find that YukBA dimerizes to form a 
hexamer of enzymatic subunits that show differential ATPase requirements for protein secretion.  
Interestingly, we find a requirement for rotational symmetry in the nucleotide binding/hydrolysis 
activity of subunits that has not been previously described in the study of other ATPases. 
 
3A.2 Results 
 
Domain structure of ESX-encoded ATPases 
One defining feature of all ESX loci is the presence of an FtsK/SpoIIIE family ATPase.  In 
contrast to the canonical members of this protein family, which have a single ATPase domain, 
ESX-associated ATPases possess multiple (2-3) nucleotide binding domains.  In fact, among 
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ATPases of the FtsK/SpoIIIE family, the presence of multiple enzymatic domains is unique to 
ESX-associated ATPases (Pallen 2002, Figure 3A-1A).  Studies of ESX-type systems from 
multiple organisms have demonstrated that these locus-encoded ATPases are required for the 
proper functioning of the secretion system, as determined by the secretion of the conserved EsxA-
like substrate protein (Stanley 2003, Burts 2005, Akpe San Roman 2010). 
 
The B. subtilis ESX-type secretion system is encoded within a five gene operon, currently termed 
the yuk operon, which includes the FtsK/SpoIIIE family ATPase YukBA and the EsxA 
homologue YukE (São-José 2004).  (In the original annotation of the B. subtilis genome a 
sequencing error caused yukB and yukA to be annotated as two separate open reading frames.  
Upon correction, this single gene was named yukBA (São-José 2004)).  YukBA contains three 
ATPase domains, each identifiable by a Walker A motif (GXXXXGKT/S), the conserved 
nucleotide binding motif common to all P-loop NTPases (Walker 1982, Saraste 1990) (Figure 
3A-1A).  The conserved lysine (K) residues of these three motifs are located at amino acids 
K688, K1016 and K1299 of the YukBA protein.   We have recently demonstrated that the yuk 
locus operates as a canonical ESX-type secretion system, where each gene within the operon is 
required for the secretion of YukE (Huppert et al., in preparation).  Therefore, we use YukE 
secretion as an assay for YukBA function (Figure 3A-1B). 
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Figure 3A-1.  ESX-encoded ATPases. 
(A). Protein domain structure of the ESX-encoded ATPases of B. subtilis, B. anthrasis and M. 
tuberculosis ESX-1 and ESX-3 loci.  ATPase domains are indicated by blue boxes.  Amino acid 
position of the B. subtilis YukBA Walker A motif active site lysine of each ATPase domain is 
indicated.  (B). Immunoblot demonstrating the requirement for YukBA for YukE secretion.  Cell 
pellet (P) and culture supernatant (S) samples were separated by SDS-PAGE under reducing 
conditions and analyzed by immunoblot with an α-YukE antibody.  An antibody to SigmaA was 
used as a lysis and loading control. 
 
 
YukBA is a dimer 
Crystal structures of many AAA+ family ATPases have shown that these enzymes assemble as 
homo- or heterohexameric ring-shaped oligomers.  Likewise, FtsK, the canonical FtsK/SpoIIIE 
family ATPase, functions as a hexameric ring made up of six identical protein subunits (Massey 
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2006).  However, it was unclear how the multiple nucleotide-binding domains of ESX-associated 
ATPases would assemble.  We postulated that these proteins might dimerize, to create a 
functional hexameric complex containing six ATPase domains, or could form a homohexameric 
protein complex. 
 
To address this question, we defined the oligomeric state of the ESX-associated ATPase YukBA 
of B. subtilis using gel-exclusion chromatography to assess the size of the native protein complex.  
As YukBA is a 171 kDa integral membrane protein, we isolated a crude membrane fraction from 
B. subtilis ectopically expressing a functional copy of YukBA-Myc and then solubilized 
membrane proteins with the non-ionic detergent dodecyl-β-D-maltoside (DDM).  The clarified 
detergent-soluble membrane fraction was resolved on a Sephacryl S-300 column; fractions were 
analyzed by SDS-PAGE, followed by immunoblot analysis with anti-Myc antibodies.  In order 
obtain solublized YukBA-Myc, we expressed this protein in a variety of bacterial strain 
backgrounds.  When expressed in B. subtilis ∆yukE, we identified a single peak of YukBA-Myc 
eluting at a predicted molecular weight of ~450-380 kDa (Figure 3A-2).  This molecular weight is 
consistent with that of a YukBA dimer, corrected for the predicted molecular weight of a DDM 
micelle (70 kDa) (Linke 2009).  These results suggest that YukBA dimerizes to create a 
functional complex containing six ATPase domains.  We hypothesize that this complex is 
functionally equivalent to the ring-shaped hexamers formed by AAA+ family ATPases.   
Interestingly, in wild-type cells we could not resolve the size of YukBA, as the protein eluted 
only in the void volume (data not shown).  While we cannot rule out technical explanation for 
these findings, it is possible that in the presence of substrate a higher order protein complex is 
formed.   
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Figure 3A-2.  YukBA is a dimer. 
Immunoblot of eluted fractions containing YukBA-Myc.  The detergent solublized membrane 
fraction from a ∆yukE, yukBA-myc strain was applied to a Sephacryl S-300 gel filtration column.  
Eluted fractions were concentrated by TCA precipitation, separated on an SDS-PAGE gel under 
reducing conditions, and analyzed by immunoblot with α-Myc antibodies.  YukBA-Myc is 
detected in fractions corresponding to a molecular weight between ~450-380 kDa.  Fraction 
number and elution profile of reference proteins are indicated (thyroglobulin, 669 kDa; ferritin, 
440 kDa; catalase, 232 kDa; aldolase, 158 kDa).  Bottom panel indicates predicted molecular 
weight of YukBA oligomeric forms (accounting for the size of an associated DDM micelle).   
 
The ATPase domains of YukBA are differentially required for YukE secretion 
Heterohexamers, by definition, are composed of nonidentical enzymatic subunits.  The six active 
sites of the oligomeric enzyme can contribute equally to function, or they can be functionally 
nonequivalent.  Therefore, we sought to determine the requirements for each of the three 
structurally distinct active sites within the YukBA dimer.  To do so, we inactivated each domain, 
both singly and in combination, by mutating the conserved lysine (K) residue to an alanine (A).  
This mutation has previously been shown to prevent ATP binding, thereby rendering the 
enzymatic activity of the ATPase domain nonfunctional (Omote 1992, Stephens 1995).  We then 
tested the ability of each mutant protein to complement B. subtilis ∆yukBA for YukE secretion. 
As seen in Figure 3A-3, the introduction of a wild-type copy of YukBA into ∆yukBA successfully 
restores YukE secretion.  When the most N-terminal ATPase domain of YukBA is mutated, 
YukBA
K688A, the expression of this protein fails to complement ∆yukBA for YukE secretion 
(Figure 3A-3A).  This is true when this domain is mutated singly or in any combination 
(yukBA
K688AK1016A
, yukBA
K688AK1299A
, or yukBA
K688AK1016AK1299A
).  Therefore, the YukBA
K688
 
nucleotide binding domain is fully required for YukE secretion.  In contrast, when YukBA
K1016
 or 
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YukBA
K1299
 are mutated, these single mutant proteins are fully able to restore YukE secretion in 
∆yukBA.  Likewise, when the YukBAK1016AK1299A double mutant protein is expressed in the 
∆yukBA strain, this protein is fully able to restore YukE secretion.  These results demonstrate that 
YukBA
K1016
 and YukBA
K1299
 are not required for YukE secretion, neither individually or in a 
redundant fashion.  From these results we can conclude that the three ATPase domains of YukBA 
are differentially required for secretion, as the activity of only the most N-terminal domain, 
YukBA
K688
, is required for secretion.   
 
From these results, we cannot distinguish whether the requirement of YukBA
K688
 is at the level of 
ATP binding or ATP hydrolysis, as the lysine (K) to alanine (A) mutation is known to prevent 
ATP binding and therefore ATP hydrolysis cannot occur.  To address the possibility that YukE 
secretion may require nucleotide binding, we also made lysine (K) to threonine (T) mutations 
within each Walker A motif of YukBA, as this mutation has been shown in some systems to 
allow ATP binding but prevent ATP hydrolysis.  We found each YukBA K to T mutant strain to 
have the same phenotype as the corresponding K to A mutant strain, in regards to the ability to 
complement ∆yukBA for secretion (Figure 3A-3B).  Though these results do not suggest distinct 
requirements for ATP binding versus hydrolysis, in vitro ATPase assays will be necessary to 
verify the nucleotide binding properties of each YukBA mutant.   
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Figure 3A-3.  YukBA
K688
 is required for YukE secretion. 
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Figure 3A-3 (continued).  (A). and (B). Immunoblot analysis of cell pellet (P) and culture 
supernatant (S) of indicated strains grown in LB media.  Each yukBA Walker A motif mutant was 
C-terminally myc-tagged, fused to an IPTG-inducible promoter (Phyperspank), and inserted in single 
copy at a nonessential locus in the chromosome of the ∆yukBA strain.  YukBA K to A (A) and K 
to T (B) Walker A motif mutants were assayed.  Reduced P and S samples were separated on an 
SDS-PAGE gel and analyzed by immunoblot with YukE-specific antibodies.  An α-Myc antibody 
was used to verify expression of the YukBA complementing constructs; an antibody to SigmaA 
was used as a lysis and loading control.  (C). YukE secretion was quantitated through 
densitometry of the YukE-specific band in the supernatant of each strain.  The level of YukE 
secretion is presented as the percentage of secretion in each ∆yukBA strain complemented with a 
yukBA Walker A mutant allele as compared to a ∆yukBA strain complemented with wild-type 
yukBA.  Data represent the mean + standard deviation of 4 biologic replicates (K to A strains) or 2 
biologic replicates (K to T strains).  
 
Each ATPase domain of YukBA is functional and dominant 
In addition to providing energy to power substrate translocation, the enzymatic activity of 
ATPases can be required for the proper assembly or stability of protein complexes involving 
components of the secretion machine.  One way to distinguish between these possible functions is 
to assess whether an ATPase mutant protein displays functional dominance when expressed in the 
presence of a wild-type copy of the protein.  A dominant phenotype suggests that the mutant 
protein is able to enter into a complex with wild-type protein, but cannot provide the energy 
required for substrate translocation, thereby rendering the complex nonfunctional.  If dominance 
is not seen, it suggests that the mutant protein is not able to enter into complexes with wild-type 
proteins and ATPase activity may be required for complex formation. 
 
To assess whether the enzymatic activity of YukBA
K688
 is required for complex formation or 
substrate translocation, we created a merodiploid strain ectopically expressing the YukBA
K688A 
mutant in an otherwise wild-type B. subtilis strain and assayed YukE secretion.  Analysis of the 
culture supernatant of the YukBA
K688A
 expressing merodiploid strain showed a >80% reduction in 
YukE secretion (Figure 3A-4A).  Likewise, when yukBA
K688A 
is mutated in combination with 
either other Walker A motif (yukBA
K688AK1016A
, yukBA
K688AK1299A
, or yukBA
K688AK1016AK1299A
), we see 
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dramatically reduced YukE secretion as compared to the wild-type control.  We quantitated the 
level of YukE in the supernatant of each mutant strain as compared to the wild-type merodiploid 
strain expressing wild-type YukBA (Figure 3A-4C).  These results suggest that the enzymatic 
activity of YukBA
K688
 is not required for complex formation, but two functional YukBA
K688
 
domains are required for secretion.  In agreement with our previous findings, we did not see 
significant differences in dominance between strains where the Walker A motif lysine (K) of 
YukBA was mutated to an alanine (A) versus a threonine (T) (Figure 3A-4B).   
 
Surprisingly, when YukBA
K1016 
or YukBA
K1299
 was mutated, individually or in combination, 
these mutants show a dominant effect on YukE secretion (Figure 3A-4A/B).  These results are 
independent of whether the Walker A motif lysine (K) was mutated to alanine (A) or threonine 
(T).  Therefore, though these domains are not required for secretion, they are functional and play 
a role that requires the ability to bind and/or hydrolyze ATP.  Most interestingly, these data reveal 
a requirement for rotational symmetry in the nucleotide binding state between domains across the 
hexamer (Figure 3A-5C). 
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Figure 3A-4.  Each YukBA Walker A motif mutant is dominant over wild-type. 
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Figure 3A-4 (continued).  (A). and (B).  Immunoblot analysis of cell pellet (P) and culture 
supernatant (S) of indicated strains grown in LB media.  Each yukBA ATPase mutant gene was C-
terminally myc-tagged, fused to an IPTG- inducible promoter (Phyperspank), and inserted in single 
copy at a nonessential locus in the chromosome of an otherwise wild-type strain.  YukBA K to A 
(A) and K to T (B) ATPase mutants were assayed.  Reduced P and S samples were separated on 
an SDS-PAGE gel and analyzed by immunoblot with YukE-specific antibodies.  An α-Myc 
antibody was used to verify expression of the YukBA complementing constructs, and an antibody 
to SigmaA was used as a lysis and loading control.  (C). YukE secretion was quantitated through 
densitometry of the YukE-specific band in the supernatant of each strain.  The level of YukE 
secretion is presented as the percentage of secretion in each yukBA mutant-expressing 
merodiploid strain as compared to a wild-type strain expressing wild-type yukBA.  Data represent 
the mean + standard deviation of 4 biologic replicates (K to A strains) or 2 biologic replicates (K 
to T strains).  
 
3A.3 Discussion 
 
The FtsK/SpoIIIE family ATPases of ESX-type secretion systems uniquely contain multiple 
ATPase domains.  This is a distinguishing feature of this class of enzymes, but the structural and 
functional consequences of this domain organization are unknown.  We propose that the native 
conformation of YukBA is a dimer, thereby forming a complex with six ATPase domains.  The 
simplest model is that YukBA forms a head-to-tail dimeric ring to produce a functional hexamer.  
This configuration, as opposed to a head-to-head interaction, most easily ensures that the same 
face of each domain is oriented toward the inner surface of the hexameric ring upon dimerization 
(Figure3A-5B).    
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Figure 3A-5.  Models demonstrating the functional requirements of YukBA. 
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Figure 3A-5 (continued).  (A). Protein domain structure of YukBA.  ATPase domains are 
indicated by blue boxes; amino acid position of each Walker A motif active site lysine is 
indicated.  (B). Two possible conformations of a YukBA dimer.  A head-to-tail configuration 
ensures that the same face of each domain is orientated toward the inner surface of the ring.  (C). 
Secretion phenotype of dimers formed by YukBA single, double, and triple Walker A motif 
mutant proteins, in the absence or presence of wild-type YukBA.  Domains shaded grey and 
outlined in red represent domains that have been rendered inactive through mutation of the 
Walker A motif active site lysine (K).   
 
The mechanism by which a hexameric ATPase couples the energy from ATP hydrolysis to the 
mechanical movement necessary for substrate translocation is poorly understood for most 
enzymes.  There are currently three primary models used to describe the firing pattern among the 
subunits of a hexamer:  concerted, sequential, and probabilistic.  The six subunits of an enzyme 
can equally contribute to function, or the subunits within an enzyme can be differentially required 
for function.  The inherent domain structure of ESX ATPases provides a natural linked subunit 
model, allowing us to introduce mutations in known geometric arrangements and test the 
functional consequences on protein secretion.  Here, we find that the six ATPase domains within 
a YukBA dimer are differentially required for YukE secretion.  ATP binding/hydrolysis by most 
N-terminal domain, YukBA
K688
, is absolutely required, while YukBA
K1016
 and YukBA
K1299
 are 
not required for YukE secretion.  These results are inconsistent with a model requiring all six 
domains within a hexamer to fire synchronously, such as the all subunit concerted model.  The 
data also rule out other models in which all six ATPase domains must fire in order to power 
secretion, including an obligate sequential model.  Additionally, our data exclude a probabilistic 
firing pattern, because in this model, as currently conceived, all subunits are equivalent and any 
subunit can be rendered inactive without consequence to overall enzyme function, as long as the 
minimum number of active subunits is retained.  Each of the above models of ATPase firing can 
be edited to describe the firing pattern between only a subset of subunits within a hexamer, the 
designated active subunits.  For example, ATP hydrolysis by the F1-ATPase, which is composed 
of alternating catalytic and noncatalytic subunits, occurs in a defined rotary sequence amongst the 
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three active subunits (Boyer 1993).  This mechanism of action has been designated a three-site 
sequential model.  Likewise, in our system, the two YukBA
K688
 domains may fire simultaneously, 
or alternatively, they may fire sequentially or completely independent of one another.  Currently, 
we cannot distinguish between these possibilities.  
 
Using a test of dominance we find that the YukBA
K1016
 and YukBA
K1299
 domains are functional, 
but not required for YukE secretion.  Interestingly, YukBA function requires rotational symmetry 
within a dimeric complex, such that the opposing subunits within the ring are in the same phase 
as one another (Figure 3A-5C).  For example, when the two YukBA
K1016
 domains within a 
hexamer are both wild-type or are both mutated, such that they are in the same nucleotide binding 
state as one another, the resulting YukBA dimer is functional and YukE is secreted at wild-type 
levels.  But, when the two YukBA
K1016
 domains within a dimer are out of phase with each other, 
as is the case upon dimerization of one wild-type YukBA protein with one YukBA
K1016A
 mutant 
protein, the complex is no longer able to function.  Likewise, the YukBA
K1299
 Walker A motif 
shows this same requirement for rotational symmetry. 
 
We envision a model in which the YukBA dimer is anchored at the cell membrane through the N-
terminal transmembrane domains of each monomer.  Upon substrate interaction, the two 
YukBA
K688
 domains act as the primary catalytic subunits, coupling the hydrolysis of ATP to 
move YukE across the cell membrane.  The remaining four active sites within the dimer, 
YukBA
K1016
 and YukBA
K1299
 from each monomer, may act in a regulatory capacity to coordinate 
the firing pattern of the catalytic subunits.  For secretion to occur, each domain must be in register 
with the active site across the hexameric ring, demonstrating a strict requirement for intersubunit 
communication for function.  
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3A.4 Materials and Methods 
 
Culture of B. subtilis and preparation of whole cell pellets and culture supernatants 
All B. subtilis strains were derived from the prototrophic strain PY79 (Youngman 1983).  Strains 
were maintained in Miller LB broth (Acros, New Jersey, USA) or on Difco Miller LB agar (BD, 
Sparks, MD).  When appropriate, antibiotics were included in the growth media as follows: 100 
μg/mL spectinomycin, 5 μg/mL chloramphenicol, 5 μg/mL kanamycin, 10 μg/mL tetracycline, 
and 1 μg/mL erythromycin plus 25 μg/mL lincomycin (mls).  Pellet and supernatant samples were 
grown and processed as described in Chapter 2.4. 
 
Strain construction and generation of complementing constructs 
General methods for molecular cloning and strain construction were performed according to 
published protocols (Sambrook 2006).  Generation of p-yukBA-myc complementing construct was 
described in Chapter 2.4.  The bacterial strains used in this study are listed in Supplemental Table 
3A-1. 
 
Site directed mutagenesis of yukBA expression vectors 
The active site lysine of each Walker A motif of YukBA was mutated to an alanine or threoinine 
using QuikChange site directed mutagenesis (Stratagene).  All mutations were introduced into the 
integrating plasmid p-amyE::hyperspank-yukBA-myc.  Double and triple mutant constructs were 
made through sequential mutation.  The following QuikChange primer pairs were used (mutated 
bases in bold): yukBAK688A (forward primer: 5’ 
GGACAACGGGATCAGGGGCGAGTGAATTTCTCCAGACC 3’; reverse primer: 5’ 
GGTCTGGAGAAATTCACTCGCCCCTGATCCCGTTGTCC 3’), yukBAK688T (forward 
primer: 5’ GGACAACGGGATCAGGGACGAGTGAATTTCTCCAGACC 3’; reverse primer: 
5’ GGTCTGGAGAAATTCACTCGTCCCTGATCCCGTTGTCC 3’), yukBAK1016A (forward 
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primer: 5’ GCTCTTCGGGCTACGGAGCGTCGATTGCAGCCGCAACG 3’; reverse primer: 5’ 
CGTTGCGGCTGCAATCGACGCTCCGTAGCCCGAAGAGC 3’), yukBAK1016T (forward 
primer: 5’ GCTCTTCGGGCTACGGAACGTCGATTGCAGCCGCAACG 3’; reverse primer: 5’ 
CGTTGCGGCTGCAATCGACGTTCCGTAGCCCGAAGAGC 3’), yukBAK1299A (forward 
primer: 5’ GCCAAACTCAGCGCGGGGCGACAAACGTCCTAAAAGTC 3’; reverse primer: 
5’ GACTTTTAGGACGTTTGTCGCCCCGCGCTGAGTTTGGC 3’), yukBAK1299T (forward 
primer: 5’ GCCAAACTCAGCGCGGGACGACAAACGTCCTAAAAGTC 3’; reverse primer: 
5’ GACTTTTAGGACGTTTGTCGTCCCGCGCTGAGTTTGGC 3’).  All constructs were 
confirmed by sequencing. 
 
Preparation of detergent solublized membrane fractions 
B. subtilis cultures started from a single colony were normalized to an OD600 of 0.02 in LB 
media (50 mL cultures) and grown 2 hours at 37
oC, at which time 100 μM IPTG was added to 
induce protein expression; cultures were grown an additional 2 hours.  Cell pellets were harvested 
by centrifugation and washed two times with 1X SMM (0.5 M Sucrose, 20 mM MgCl2, 20 mM 
Maleic acid pH 6.5) at room temperature. Cells were resuspended in 10 mL 1x SMM and 
protoplasted with 1mg/ml lysozyme.  Protoplasts were collected by centrifugation and flash 
frozen in liquid N2.  Thawed protoplasts were disrupted by osmotic lysis with 6 mL hypotonic 
buffer (20 mM HEPES pH 8.0, 200 mM NaCl, protease inhibitor cocktail).  MgCl2 and CaCl2 
were added to 1 mM, and lysates were treated with 10 μg/ml DNase I and 20 μg/ml RNase A for 
1 hour on ice.  The membrane fraction was separated by centrifugation at 100,000 g for 1 hour at 
4
o
C.  Crude membranes were flash frozen in N2, resuspended in 2.4 mL buffer (20 mM HEPES 
pH 8.0, 200 mM NaCl, protease inhibitor) and solublized by the addition of the detergent DDM 
(n-dodecyl-B-d-maltopyranoside, Calbiochem, La Jolla, CA) to a final concentration of 1%.  This 
mixture was incubated at 4
o
C for 1 hour.  Membrane soluble and insoluble fractions were 
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separated by centrifugation at 100,000 g for 1 hr at 4
o
C.   
 
Sizing by FPLC 
The membrane soluble fraction was diluted 10-fold in buffer (20 mM Hepes pH 8.0, 200 mM 
NaCl) to give a final DDM concentration of 0.1%.  Sample was spun at 100,000 g for 1 hr at 4
o
C 
to remove any precipitate.  0.5 mL sample was loaded onto a HiPrep 16/60 Sephacryl S-300 HR 
column (GE Healthcare) equilibrated with buffer (20 mM Hepes pH 8.0, 200 mM NaCl, 0.1% 
DDM).  1 mL fractions were collected and concentrated by precipitation with 10% TCA, 
resuspended in SDS sample buffer (6x, nonreducing SDS sample buffer, Boston BioProducts), 
and analyzed by immunoblot.  Reference proteins used for calibration were thyroglobulin (669 
kDa), ferritin (440 kDa), catalase (232 kDa), and aldolase (158 kDa) (HMW Gel Filtration 
Calibration Kit, Amersham). 
 
SDS-PAGE and immunoblot analysis 
Prior to analysis, samples were reduced with 100 mM DTT for 1 hour at 37
o
C.  Proteins were 
separated by SDS-PAGE and transferred to a nitrocellulose membrane (Bio-Rad) for immunoblot 
analysis.  Membranes were probed with anti-YukE (1:1,000) and anti-Myc (1:3,000, ab9106, 
Abcam, Cambridge, MA).  A peroxidase-conjugated goat anti-rabbit secondary antibody 
(1:3,000, ab6721, Abcam, Cambridge, MA) was detected by chemiluminescence using 
SuperSignal West Femto (Thermo Scientific).  An antibody to the abundant, cytosolic protein 
SigmaA was used to ensure equal protein loading and as a lysis control (1:1,000,000, Fujita 
2000).  Blots were imaged and densitometric quantitation of YukE secretion was performed using 
a FluorChem FC2 gel documentation system (Alpha Innotech) and provided software.   
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3A.5 Supplementary Materials 
Strain GenotypeA Source/Reference
PY79 Prototrophic domesticated laboratory strain Youngman 1983
bLH015 yukE::erm-Pyuk Chapter 2
bLH110 yukBA::erm-Pyuk Chapter 2
bLH266 amyE::Phyperspank-yukBA-myc This Chapter
bLH267 amyE::Phyperspank-yukBA-K688A-myc This Chapter
bLH268 amyE::Phyperspank-yukBA-K1016A-myc This Chapter
bLH269 amyE::Phyperspank-yukBA-K1299A-myc This Chapter
bLH318 amyE::Phyperspank-yukBA-K688AK1016A-myc This Chapter
bLH319 amyE::Phyperspank-yukBA-K688AK1299A-myc This Chapter
bLH320 amyE::Phyperspank-yukBA-K1016AK1299A-myc This Chapter
bLH321 amyE::Phyperspank-yukBA-K688AK1016AK1299A-myc This Chapter
bLH397 amyE::Phyperspank-yukBA-K688T-myc This Chapter
bLH398 amyE::Phyperspank-yukBA-K1016T-myc This Chapter
bLH399 amyE::Phyperspank-yukBA-K1299T-myc This Chapter
bLH400 amyE::Phyperspank-yukBA-K688TK1016T-myc This Chapter
bLH401 amyE::Phyperspank-yukBA-K688TK1299T-myc This Chapter
bLH402 amyE::Phyperspank-yukBA-K1016TK1299T-myc This Chapter
bLH403 amyE::Phyperspank-yukBA-K688TK1016TK1299T-myc This Chapter
bLH404 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-myc Chapter 2
bLH405 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-K688A-myc This Chapter
bLH406 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-K1016A-myc This Chapter
bLH407 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-K1299A-myc This Chapter
bLH408 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-K688AK1016A-myc This Chapter
bLH409 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-K1016AK1299A-myc This Chapter
bLH410 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-K688AK1299A-myc This Chapter
bLH411 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-K688AK1016AK1299A-myc This Chapter
bLH412 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-K688T-myc This Chapter
bLH413 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-K1016T-myc This Chapter
bLH414 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-K1299T-myc This Chapter
bLH415 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-K688TK1016T-myc This Chapter
bLH416 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-K1016TK1299T-myc This Chapter
bLH417 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-K688TK1299T-myc This Chapter
bLH418 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-K688TK1016TK1299T-myc This Chapter
 
 
Supplemental Table 3A-1. Strains used in this study. 
A 
All strains are isogenic with the B. subtilis laboratory wild-type strain PY79 unless otherwise 
indicated; “3610” indicates that the strain is isogenic with the B. subtilis undomesticated wild-
type strain 3610. 
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Chapter 3B: EccCa-EccCb ATPase requirements for ESX-1 secretory 
activity 
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3B.1 Introduction 
 
The ESX-1 secretion system of Mycobacterium tuberculosis (Mtb) was the first identified ESX-
type secretion system, and it has been shown to be a major virulence determinant of this human 
pathogen.  The Mtb ESX-1 secretion system is encoded within a 20 gene locus responsible for the 
secretion of six protein substrates: EsxA, EsxB, EspA, EspB, EspC, and EspR (Sørensen 1995, 
Berthet 1998, Fortune 2005, MacGurn 2005, Xu 2007, McLaughlin 2007, Raghavan 2008).  
While many genes within the locus have been shown to be required for functional secretion, the 
mechanism by which apparatus components assemble and translocate these substrates is poorly 
understood.  Through the study of discrete components of this system, we and others aim to better 
understand the mechanism by which this alternative protein secretion system functions and 
mediates pathogenesis.   
 
Within every genetic locus encoding for an ESX-type secretion system, there is an ATPase 
containing multiple FtsK/SpoIIIE family ATPase domains (Pallen 2002).  In contrast to most 
ESX-associated ATPases of this family, which are encoded for by a single polypeptide, the 
ATPase of the Mtb ESX-1 locus was divided into two genes, eccCa and eccCb, during the 
evolution of the ESX-1 genetic duplication (Gey van Pittius 2001).  eccCa contains one ATPase 
domain, identifiable by a conserved Walker A nucleotide binding motif, while eccCb contains 
two Walker A motifs (Figure 3B-1).  The EccCa and EccCb proteins are predicted to work 
together as a single functional unit to power ESX-1 secretion.  In agreement with this prediction, 
using a yeast-two hybrid system, EccCa and EccCb have been shown to interact in vitro (Stanley 
2003). 
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Figure 3B-1.  Mtb ESX-1-encoded ATPases EccCa-EccCb.  
(A). Protein domain structure of the Mtb ESX-1-encoded ATPases EccCa-EccCb.  ATPase 
domains are indicated by blue boxes; amino acid position of the Walker A motif active site lysine 
of each ATPase domain is indicated.     
 
To investigate the mechanism by which ESX-1 functions, we have sought to understand the role 
of the locus-encoded FtsK/SpoIIIE family ATPases eccCa and eccCb in ESX-1-mediated 
secretion.  Additionally, in Chapter 3A, we demonstrated that only the most N-terminal ATPase 
domain of the B. subtilis ESX-associated ATPase YukBA was required for the function of the yuk 
secretion system, while the second and third domains of this protein play a non-required role.  
Given the split protein architecture of the Mtb ESX-1-encoded ATPases, we sought to determine 
if EccCa-EccCb show parallel domain requirements, or if the added complexity of the split 
protein reveal differential domain requirements between the two systems. 
 
3B.2 Results 
 
Each ATPase domain of EccCa-EccCb is required for ESX-1-mediated secretion 
The deletion of eccCa or eccCb has previously been shown to block ESX-1-mediated secretion 
(Stanley 2003, Guinn 2004).  To verify these findings in our experimental system, we assessed 
the secretion of known ESX-1 substrates in strains containing a transposon insertion in either 
eccCa (eccCa::Tn) or eccCb (eccCb::Tn).  Using immunoblot analysis and protein-specific 
antibodies, we looked for the expression and secretion of EsxA, EsxB, and EspA in each 
transposon mutant strain as compared to wild-type H37Rv.  As a negative control, we included a 
ΔRD1 knockout strain, which lacks esxA and esxB, and has previously been shown not secrete 
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EspA (Fortune 2005).  In agreement with previously published results, the eccCa::Tn and 
eccCb::Tn strains do not secrete EsxA, EsxB, or EspA (Figure 3B-2).  Expression of eccCa-
eccCb in tandem from an episomal construct restores secretion in the eccCa::Tn mutant strain.  
(Expression of eccCa alone did not restore secretion; it is likely that this is due to a polar effect of 
the transposon insertion on the downstream eccCb gene).  Likewise, episomal expression of 
eccCb restores the secretion of ESX-1 substrates in the eccCb::Tn strain.      
 
To test the requirements for functional EccCa and EccCb ATPase activity for ESX-1 secretion, 
we mutated the conserved lysine (K) in each Walker A motif to an alanine (A) and then tested the 
ability of each mutant protein to complement ESX-1 secretion in an eccCa- or eccCb-null strain.  
The expression of the EccCa
K485A
 ATPase mutant (in tandem with wild-type EccCb) failed to 
restore the secretion of EsxA, EsxB, and EspA in eccCa::Tn (Figure 3B-2).  Likewise, each 
EccCb ATPase mutant protein (EccCb
K90A
, EccCb
K382A
, and the EccCb
K90AK382A
 double mutant) 
was unable to complement eccCb::Tn for secretion.  These results demonstrate that the ATPase 
activity of each individual nucleotide binding domain of EccCa-EccCb is required for ESX-1 
secretion.   
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Figure 3B-2.  Each ATPase domain of EccCa-EccCb is required for ESX-1-mediated 
secretion. 
Immunoblot analysis of cell pellet (P) and culture supernatant (S) of the indicated strains grown 
in Sauton’s media.  Samples were separated by SDS-PAGE under reducing conditions and 
analyzed for ESX-1 secretion using antibodies specific to the ESX-1 substrates EsxA, EsxB, and 
EspA.  In each complementing construct, eccCb was C-terminally flag-tagged.  An antibody to E. 
coli RNAP was used as a lysis and loading control.  Data are representative of at least two 
independent experiments. 
 
Some EccCa-EccCb ATPase mutants are dominant negative on ESX-1-mediated secretion 
Secretion system-associated ATPases can provide energy for various steps in the secretion 
process, including the recruitment or assembly of secretion apparatus components, as well as 
substrate translocation.  It is possible that the three ATPase domains of EccCa and EccCb are 
differentially required for these processes.  To address whether the enzymatic activity of EccCa 
and/or EccCb is required to mediate protein-protein interactions, we asked whether the Walker A 
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motif mutant forms of these proteins show dominance over wild-type.  We reasoned that if the 
ATPase mutant EccCa or EccCb proteins are still able to enter into protein complexes, then their 
expression in a wild-type background will result in reduced ESX-1 secretion due to the mutant 
protein interfering with wild-type transport complexes.   
 
To determine whether the EccCa and EccCb Walker A motif mutants display transdominance, we 
expressed each mutant from an inducible episomal vector in a wild-type strain of Mtb and 
assayed for functional ESX-1 secretion.  We find that the expression of EccCa
K485A
, EccCb
K90A
, 
or EccCb
K382A
 results in a dominant negative effect on secretion, as demonstrated by the reduced 
levels of EsxA, EsxB, and EspA in the culture supernatant of these merodiploid strains as 
compared to wild-type (Figure 3B-3).  This phenotype is not simply due to an abundance of 
EccCa or EccCb within the cell, as overexpression of wild-type copies of these genes does not 
effect secretion.  The transdominant phenotype displayed by the three single EccCa-EccCb 
ATPase mutants provides strong genetic evidence that these proteins function as part of a protein-
protein complex, in accordance with previously published data. 
 
Interestingly, the EccCb
K90AK382A
 double mutant protein shows a significant relief in the 
dominance phenotype as compared to the single EccCb mutants (Figure 3B-3).  While the level of 
secretion in this strain is not that of wild-type, it is significantly greater than is seen with the 
expression of any single mutant.  These results suggest that some ATPase activity is required for 
EccCb to form stable protein complexes.  Although an alternative explanation of these results is 
that there is a gross structural malformation of the EccCb
K90AK382A
 protein, this is not likely as a 
lysine (K) to alanine (A) substitution is known to be structurally conservative and immunoblot 
analysis of the cell pellet shows that the EccCb
K90AK382A
 mutant protein is both expressed and 
stable.   
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Figure 3B-3.  Some ATPase domains of EccCa-EccCb are dominant over wild-type. 
Immunoblot analysis of cell pellet (P) and culture supernatant (S) of the indicated strains grown 
in Sauton’s media.  Samples were separated by SDS-PAGE under reducing conditions and 
analyzed for ESX-1 secretion using antibodies specific to the ESX-1 substrates EsxA, EsxB, and 
EspA.  In each complementing construct, eccCb was C-terminally flag-tagged.  An antibody to E. 
coli RNAP was used as a lysis and loading control.  Data are representative of at least three 
independent experiments. 
 
3B.3 Discussion 
 
The ESX-associated FtsK/SpoIIIE family ATPases uniquely contain multiple enzymatic domains.  
While the ESX-1 genes eccCa and eccCb encode two polypeptides, genetic and biochemical 
evidence suggest that these proteins act together as a single functional unit, thereby forming a 
complex with a total of three ATPase domains.  We find that each ATPase domain is individually 
required for ESX-1-mediated secretion.  Additionally, we provide strong genetic evidence that 
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EccCa and EccCb function as part of a protein complex, either with each other and/or other 
components of the secretion system.  Interestingly, EccCb-mediated dominance is relieved upon 
mutation of both active sites within the protein (EccCb
K90AK382A
), suggesting that some energy 
from ATP binding or hydrolysis is required to either form or stabilize EccCb-containing 
complexes.   
 
In Chapter 3A we demonstrate that the B. subtilis ESX-associated ATPase YukBA forms a 
dimeric complex and we propose that the six ATPase domains of this YukBA dimer form a 
hexameric ring of active sites, as is common to many AAA+ ATPases.  We hypothesize that this 
structural assembly is conserved among ESX-associated ATPases, and that in the Mtb ESX-1 
system, two EccCa and two EccCb proteins interact to form and function as a hexameric ring 
containing six ATPase domains. 
 
The ESX-1 secretion system of Mtb and the ESX-type yuk secretion system of B. subtilis show 
differential energetic requirements for substrate secretion.  While each ATPase domain within 
EccCa-EccCb is required for secretion, only the most N-terminal ATPase domain of YukBA is 
required for functional secretion.   We hypothesize that, given the like requirement for the most 
N-terminal domain of each enzyme (EccCa
K485
 and YukBA
K688
), these domains represents a 
function common to both systems.  Given that our data suggests that this domain is not required 
for these proteins to enter into protein-protein complexes, we propose that the energy derived 
from ATP hydrolysis by EccCa
K485
 and YukBA
K688
 is directly coupled to substrate translocation.   
 
One possible explanation for the additional requirement for the enzymatic activity of the two 
ATPase domains of EccCb is that, due to the split architecture of EccCa and EccCb, energy is 
required to mediate the interaction between these two proteins.  In this model, having one 
functional EccCb ATPase domain is sufficient to produce a functional complex, but without the 
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energy derived from ATP hydrolysis from either of these domains, the interaction between EccCa 
and EccCb is too weak to form a stable, ring-shaped complex.  Additionally, EccCb ATPase 
activity may be used to recruit substrates or regulate the interaction of substrates with the pore of 
the secretion machine to control the timing and specificity of secretion.  These activities could 
represent Mtb-specific requirements, for example, to either direct the secretion of multiple 
substrates or to tightly regulate secretion upon interaction with a host cell.   
 
Finally, we previously demonstrated that although the enzymatic activity of YukBA
K1016
 and 
YukBA
K1299
 of B. subtilis is not required for YukE secretion, these domains must be in the same 
nucleotide binding state as the corresponding domain across the hexameric ring.  We predict that 
the EccCa-EccCb dimeric ring also requires this radial symmetry, but our ability to see this 
requirement is overshadowed by the requirement for these domains to mediate the interaction 
with EccCa. 
 
3B.4 Materials and Methods 
 
Culture of Mtb and preparation of whole cell pellets and culture supernatants 
Mtb (H37Rv) strains were maintained in Middlebrook 7H9 media supplemented with oleic acid-
albumin-dextrose-catalase (OADC, Difco) and 0.05% Tween 80.  The generation of H37Rv∆RD1 
(Lewis 2003) and the identification and confirmation of the Rv3870::Tn (eccCa::Tn) and 
Rv3871::Tn (eccCb::Tn) transposon mutant strains have been previously described (Guinn 2004).   
 
For analysis of protein expression and secretion, bacterial cultures grown to mid-log phase were 
normalized to an OD600 of 0.3 in fresh 7H9 media supplemented with OADC, 0.05% Tween 80 
and 100 ng/ml anhydrotetracycline (AT, Spectrum Chemicals, Gardena, CA), when appropriate.  
Cultures were grown overnight at 37
o
C to induce gene expression of the complementing construct 
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24 hours prior to beginning culture supernatant collections.  Cultures were pelleted, washed, 
resuspended in Sauton’s media supplemented with 0.05% Tween 80 and AT and grown for 48 
hours at 37
o
C.  Cell pellets were collected by centrifugation, resuspended in protein extraction 
buffer (50 mM Tris∙HCL pH 7.5, 5 mM EDTA, protease inhibitor cocktail) and disrupted by bead 
beating.  SDS sample buffer (Novex 2x Tricine SDS sample buffer, Invitrogen) was added and 
samples were heated at 95
o
C for 20 minutes before removal from the biosafety level 3 facility.  
Protease inhibitor cocktail was added to the culture supernatants, which were then sterilized by 
double filtration through 0.2 μM filters.  The culture supernatants were concentrated by 
precipitation with 10% TCA, resuspended in SDS sample buffer and heated to 95
o
C for 20 
minutes. 
 
Generation of complementing constructs 
To generate Mtb complementing constructs, the genomic region encoding eccCa, eccCb, or 
eccCa-eccCb in tandem (including the native intergenic region), was amplified from H37Rv 
genomic DNA (eccCa forward primer: 
GGCTAAGAAGGAGATATACATATGACGACCAAGAAGTTCACT; eccCa reverse primer: 
CTTGTCGTCGTCGTCCTTGTAGTCCGGTGTCGGCGCCTCCTC; eccCb forward primer: 
GGCTAAGAAGGAGATATACATATGACTGCTGAACCGGAAGTA; eccCb reverse primer: 
CTTGTCGTCGTCGTCCTTGTAGTCACCGGCGCTTGGGGGTGC).  Forward primers added 
a ribosomal binding site (GAAGGAGATATACAT) upstream of each start codon, and the 
reverse oligo of eccCb added a C-terminal Flag-tag (protein sequence: DYKDDDDK).  A second 
round of PCR added att sites for Gateway recombination of the product and the PCR products 
were recombined into a Gateway donor vector (pDONR, Invitrogen, Carlsbad, CA) and 
transferred to an episomal expression vector (pTET), which allows for regulated gene expression 
under the control of a tetracycline inducible mycobacterial promoter (Ehrt 2005).  All constructs 
were confirmed by sequencing.  The resulting pTET constructs or an empty vector were 
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transformed into wild-type H37Rv, eccCa::Tn and eccCb::Tn strains.  These strains were 
maintained under selection with 50 μg/ml Hygromycin (Roche, Mannheim, Germany) to prevent 
plasmid loss.  
 
Site directed mutagenesis of eccCa and eccCb expression vectors 
The eccCaK485A mutation was introduced into pTET-eccCa-eccCb-flag using QuikChange site-
directed mutagenesis (Stratagene) (mutated bases in bold) (forward primer: 5’ 
GGACCACGGGGTCTGGGGCGTCCGAATTCCTGCGCAC 3’; reverse primer: 5’ 
GTGCGCAGGAATTCGGACGCCCCAGACCCCGTGGTCC 3’).  The eccCbK90A mutation 
was introduced via PCR mutagenesis and cloning of an internal gene fragment.  The fragment 
was amplified with a reverse primer that mutated lysine 90 to an alanine (forward primer: 5’ 
GGCTAAGAAGGAGATATACATATGACTGCTGAACCGGAAGTA 3’; reverse primer: 5’ 
CCATCGTCTGCAGTAGCGTCGACGCCCCGGTTTGAGGTGCGCC 3’), digested with SacI 
and PstI and ligated into vector pDONR-eccCb-flag, which had also been digested with SacI and 
PstI, to create pDONR- eccCbK90A-flag.  The construct was then transferred pTET.  The 
eccCbK382A mutation was introduced into pTET-eccCb-flag using QuikChange site-directed 
mutagenesis (Stratagene) (forward primer: 5’ 
CTACTGATCTTCGGTGCGGCCAAATCGGGCGCGACGACCATTGCCCACGCGATAGCG
CGCGCC 3’; reverse primer: 5’ 
GGCGCGCGCTATCGCGTGGGCAATGGTCGTCGCGCCCGATTTGGCCGCACCGAAGAT
CAGTAG 3’).  The eccCbK90AK382Amutant was made through the introduction of the K90A 
mutation into pTET-eccCbK382A-flag as described above.  All constructs were confirmed by 
sequencing. 
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SDS-PAGE and immunoblot analysis 
Prior to analysis, samples were reduced with 100 mM DTT for 1 hour at 37
o
C.  Proteins were 
separated by SDS-PAGE and transferred to a nitrocellulose membrane (Bio-Rad) for immunoblot 
analysis.  Membranes were probed with anti-EsxA (ESAT-6, 1:2,000, ab26246, Abcam, 
Cambridge, MA), anti-EsxB (CFP-10, 1:1,000, ab45074, Abcam, Cambridge, MA), anti-EspA 
(1:2,000, Fortune 2005) and anti-Flag (1:5,000, F7425, Sigma, Saint Louis, MO).  Peroxidase-
conjugated goat anti-rabbit (Abcam, Cambridge, MA) and goat anti-mouse (32430, Thermo 
Scientific) secondary antibodies were used at a concentration of 1:40,000 and 1:1,000, 
respectively.  Secondary antibodies were detected by chemiluminescence using SuperSignal West 
Femto (Thermo Scientific).  An antibody to E. coli RNAP was used to ensure equal protein 
loading and as a lysis control (1:1,000, WP023, Neoclone).  Equal loading of culture supernatants 
was confirmed by visualizing the total protein loaded by Coomassie staining. 
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Chapter 4: Energetic requirements of ESX-mediated cell wall functions 
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4.1 Introduction 
 
The ESX-1 secretion system is a critical mediator of virulence for the intracellular pathogen 
Mycobacterium tuberculosis (Mtb).  Despite the importance of this system, its primary function 
and the mechanism by which this system mediates virulence is unclear.  This alternative secretion 
system has historically been thought to function in a manner homologous to the type III or type 
IV secretion systems of Gram-negative bacteria, which secrete virulence effectors directly into 
the host cell environment, resulting in the modulation of the host cell for the benefit of the 
bacterium.  While this is an attractive model, the active translocation of the known ESX-1 
substrate proteins directly into the host cell cytoplasm has not been convincingly demonstrated.  
Additionally, none of the ESX-1 substrates contain functional domains common to known 
virulence effector proteins.   
 
Currently, the only ESX-1 substrate for which an in vivo virulence activity has been proposed is 
EsxA.  EsxA is hypothesized to possess membranolytic activity, resulting in the formation of 
pores in host cell membranes.  This model stems from data by Hsu et al. who used an artificial 
membrane system to show that purified EsxA could disrupt a lipid bilayer (2003).  Also using an 
in vitro system, de Jonge et al. demonstrate a strong association between purified EsxA and 
liposomes, which results in the destabilization and lysis of the liposomes (2007).  While the 
physiological relevance of the above in vitro systems can be questioned, additional studies have 
provided indirect evidence in support of ESX-1-mediated host cell cytolysis.  For example, 
strains containing deletions in ESX-1 showed a failure to lyse cells in culture (Hsu 2003, Guinn 
2004) and a loss of cell-to-cell spread in vitro (Gao 2004, Guinn 2004).  In mouse models of 
infection, ESX-1-deficient strains showed less necrosis (Junqueira-Kipnis 2006) and a lack of 
tissue invasiveness and lung damage, presumably due to a loss of bacterial egress from infected 
cells, resulting in reduce spreading (Hsu 2003).  While these studies demonstrate an association 
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between ESX-1-mediated secretion and various cytolytic pathologies, it is unclear whether these 
effects are primary or secondary to ESX-1 function.  To date, the pore-forming ability of EsxA 
remains controversial. 
 
More recently, an alternative ESX-1 function was demonstrated when Garces et al. found ESX-1 
to be a critical mediator of bacterial cell wall integrity (2010).  These results validate a long ago 
recognized connection between colony morphology, often a gross readout of cell wall 
composition, virulence, and ESX-1 (Calmette 1927, Steenken 1934, Pym 2002).  Using a 
structure-function based approach, it was demonstrated that ESX-1-mediated secretion could be 
dissociated from virulence; a strain expressing a point mutant of the substrate EspA was fully 
competent for the secretion of all known ESX-1 substrates, but was severely attenuated for 
virulence in macrophages and mice.  Most interestingly, the attenuation of this strain correlated 
with a loss of cell wall integrity, as determined by increased susceptibility to the detergent SDS, a 
known cell wall stress.  Strains lacking the ESX-1 locus or the ATPase eccCb were also more 
susceptible to detergent stress.   These data suggest that the primary target of ESX-1 is the 
mycobacterial cell wall, and that it is through this function that ESX-1 mediates virulence.   
 
The extent to which these two separable ESX-1 functions are connected is not known.  To begin 
to address this question, we sought to compare the energy requirements of secretion versus 
modulation of cell wall integrity.  Additionally, questions remain as to the primary function of 
ESX-1, and ESX-type systems more broadly.  Much of the controversy surrounding the model 
that the primary mechanism of ESX-1-associated virulence is mediated by the pore-forming 
ability of EsxA stems from the conservation of ESX-loci and EsxA in nonpathogenic bacterial 
species.  Therefore, we also sought to investigate whether ESX-1-mediated cell wall integrity 
may represent a general function of ESX-type secretion systems.  Using our B. subtilis model 
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system, we sought to test the effect of yuk operon mutations on bacterial cell wall integrity and 
biofilm formation. 
 
4.2 Results 
 
Mtb ESX-1-mediated cell wall integrity is dependent upon EccCb ATPase activity 
Prior to secretion, a regulated sequence of events must occur.  The structural components of the 
secretion apparatus must localize and assemble at the cell membrane, and likewise, the substrates 
must be recruited to this site.  In the case of a secretion system with multiple substrates, there 
must be a mechanism of substrate identification and discrimination.  Additionally, proteins often 
need to be released from a chaperone and/or unfolded prior to entrance into the translocation 
pore.  Upon the completion of these steps, the substrate can be translocated across the cell 
membrane and/or cell wall to its final destination.  Given our knowledge of the ESX-1 system, we 
can predict many of the prerequisite steps for secretion, but the steps and events required for 
ESX-1 to ensure cell wall integrity are much less clear.  It is known that ATPases can provide the 
energy to mediate any number of the aforementioned steps leading to secretion.  Therefore, we 
sought to compare the energy requirements of ESX-1-mediated secretion versus cell wall 
integrity to gain insight into the connection between these two ESX-1 functions.   
 
We hypothesize that the three ATPase domains of EccCa and EccCb may be differentially 
required for the translocation of protein substrates versus maintaining the integrity of the 
mycobacterial cell wall.  In Chapter 3B, we demonstrated that each ATPase domain within EccCa 
and EccCb is required for ESX-1-mediated secretion.  To test the requirements for EccCa-EccCb 
enzymatic activity in ensuring cell wall integrity, we assayed the effect of mutating the ATPase 
domains of these proteins on the ability of the bacterium to survive cell wall stress. 
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It has previously been shown that EccCb is required for cell survival under SDS-induced stress, 
and this cell wall defect could be complemented by restoring a wild-type copy of the gene 
(Garces 2010).  To determine whether the ATPase activity of EccCb is required for cell wall 
integrity, we tested the ability of Walker A mutant forms of this protein to restore the ability of 
the eccCb::Tn strain to survive SDS treatment.   We found that neither EccCb
K90A
 nor EccCb
K382A 
was able to complement the eccCb::Tn mutant for survival under SDS-induced stress (Figure 4-
1).  Similarly, when each single mutant protein was introduced into wild-type H37Rv, both 
resulting merodiploid strains showed an increase in SDS susceptibility as compared to wild-type.  
Thus, eccCb
K90
and eccCb
K382
 are individually required for both cell wall integrity and protein 
secretion.  (For technical reasons, the EccCa Walker A mutant was not assayed in this 
experiment).   
 
Interestingly, when eccCb::Tn was complemented with the eccCb
 
double mutant (eccCb::Tn, p- 
eccCb
K90AK382A
) this strain showed wild-type susceptibility to SDS treatment.  This restoration of 
cell wall integrity is in contrast to the inability of this mutant to restore ESX-1 secretion.  When 
expressed in a wild-type background, the double mutant protein was not dominant over wild-type, 
as demonstrated by the wild-type SDS susceptibility of the H37Rv, p-eccCb
K90AK382A 
merodiploid 
strain.  Similarly, we previously found that the eccCb
K90AK382A
 double mutant was not dominant 
over wild-type for secretion.  Together, these results suggest that the mechanism by which ESX-1 
secretes substrates is at least partially separable from the mechanism by which ESX-1 maintains 
cell wall integrity.   
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Figure 4-1.  EccCb ATPase activity is required for Mtb to survive treatment with SDS. 
To assess bacterial survival after SDS treatment, the indicated strains were grown overnight in 
Sauton’s media containing 0.1% SDS and then plated for survival (black bars).  Untreated 
bacteria were plated as a control (gray bars).  Results represent a single independent culture for 
each strain, plated for CFU in triplicate.  The mean +/- standard deviations of the triplicate 
platings are expressed.   
 
YueB overexpression by B. subtilis leads to increased susceptibility to the antibiotic 
cefuroxime 
ESX-type secretion systems are conserved among both pathogenic and nonpathogenic bacterial 
species.  This includes nonpathogenic mycobacteria, such as the soil-dwelling bacterium 
Mycobacterium smegmatis, as well as various nonmycobacterial Gram-positive species (Gey van 
Pittius 2001, Pallen 2002).  It is currently unclear whether ESX-type systems retain a conserved 
function among all species.  We and others have demonstrated that in multiple bacterial species, 
ESX-type systems function to secrete EsxA-like proteins, though the functional consequences of 
this are action unclear.  But, the conservation of a cell wall-specific ESX function has not yet 
been widely tested.  Therefore, we sought to further understand the function of the B. subtilis 
ESX-type system by characterizing a variety of phenotypic responses to loss of the yuk secretion 
system.   
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Given the increased detergent susceptibility demonstrated by Mtb ESX-1 mutants, we began by 
testing the SDS susceptibility of wild-type, ∆yukBA, and ∆yukBAyueB strains using a disc plate 
diffusion assay.  At all concentrations of SDS tested, the susceptibilities of the three strains were 
the same (data not shown). 
 
To more comprehensively screen for phenotypic changes associated with loss of the yuk secretion 
system, phenotypic microarrays of wild-type (PY79), ∆yukBA, and ∆yukBAyueB strains were 
performed in conjunction with Biolog (Haywood, CA).  Of the thousands of phenotypes tested, 
very few metabolic or chemical sensitivity tests showed differential phenotypic behavior between 
these strains.  One antibiotic, cefuroxime, showed a mild difference in efficacy against the three 
strains and warranted further validation.  Cefuroxime is a cephalosporin antibiotic which targets 
the process of bacterial cell wall synthesis.  Using a disc plate diffusion assay, we compared the 
susceptibility of wild-type B. subtilis to that of various yuk operon mutant strains.  All strains 
tested had a cefuroxime susceptibility equivalent to that of wild-type, except for ∆yukEDCBA and 
∆yukBA, which were more susceptible to cefuroxime (Figure 4-2A).  But, the ectopic expression 
of YukBA in the ∆yukBA strain did not complement the susceptibility phenotype of this deletion 
strain, suggesting that increased susceptibility to cefuroxime is not a YukBA-mediated effect 
(Figure 4-2B).   
 
Interestingly, in each of the strains demonstrating an increased susceptibility to cefuroxime 
(∆yukEDCBA, ∆yukBA, and ∆yukBA, p-yukBA), yueB is being overexpressed as a result of the 
method used to generate these deletion strains.  As described in Chapter 2, to ensure the 
expression of downstream operon genes, the native yuk promoter (Pyuk) was reinserted after the 
antibiotic resistance cassette in each knockout strain.  We found that the insertion of Pyuk directly 
upstream of yueB results in an approximate 2-3 fold increase in yueB expression as compared to  
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wild-type, and when Pyuk is inserted directly upstream of any other gene within the operon, yueB 
is expressed at wild-type levels (data not shown).  Interestingly, the gross colony morphology of 
the yueB overexpressing strains also differ from wild-type, in that the colonies are more mucoid 
and slightly smaller by visual inspection.  This variation in colony morphology is suggestive of 
cell wall changes in these strains.  YueB is a six pass transmembrane protein, and we postulate 
that increased levels of this protein may alter the cell membrane or cell wall in such a way that 
increases the cefuroxime susceptibility of the strain.  We cannot rule out the possibility that the 
insertion of the yuk promoter at this location affects the expression of another gene which is 
responsible for the increased susceptibility to cefuroxime phenotype.   
 
To determine whether the increased susceptibility to cefuroxime is specific to this antibiotic, or if 
instead these strains have a more general cell wall defect, we compared the susceptibility of wild-
type and ∆yukBA strains to other antibiotics, both those that act on the cell wall and those with 
other cellular targets.  As seen in Figure 4-2C, we did not find a difference in susceptibility of 
wild-type versus ∆yukBA to carbenicillin, kanamycin, vancomycin, chloromphenicol, or 
tetracycline.  Together, these data suggest that the increased expression of yueB causes a specific 
increase in susceptibility to the antibiotic cefuroxime.  The mechanism by which YueB may 
mediate these effects is currently not understood.   
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Figure 4-2.  Insertion of Pyuk directly upstream of yueB results in increased cefuroxime 
susceptibility. 
(A). Disc plate diffusion assays were used to determine the susceptibility of the indicated strains 
to cefuroxime.  1 μg of cefuroxime spotted on a paper disc was placed in the center of an LB agar 
plate on which a lawn of the indicated B. subtilis strain had been seeded.  After incubation 
overnight, the zone of growth inhibition surrounding the disc was measured.  (B). The disc plate 
diffusion assay was repeated with wild-type, ∆yukBA and ∆yukBA, p-yukBA strains.  IPTG was 
added to the agar of plates seeded with ∆yukBA, p-yukBA to induce the expression of the yukBA 
complementing construct.  (C). Disc plate diffusion assays were used to test the susceptibility of 
the wild-type and ∆yukBA strains to the indicated antibiotics (10 μg). 
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B. subtilis biofilm formation is dependent upon YukBA ATPase activity 
In Chapter 2, we demonstrate a role for the yuk secretion system in biofilm formation by the 
undomesticated strain B. subtilis 3610.  Upon deletion of yukBA, biofilm architecture is altered 
from that of wild-type; this phenotype is YukBA-mediated, as complementation of 3610 ∆yukBA 
with a wild-type copy of yukBA restores the biofilm to an architecture similar to that of wild-type 
3610 (Figure 2-5, Figure 4-3).  To begin to understand how the yuk locus is involved in biofilm 
formation, we sought to test whether biofilm formation has the same energetic requirements as 
YukE secretion.  To do so, we tested the ability of the YukBA Walker A motif mutant proteins to 
restore wild-type biofilm architecture when expressed in a 3610 ∆yukBA strain.  When the single 
YukBA mutants are expressed in 3610 ∆yukBA, we find that YukBAK688A does not restore biofilm 
architecture to that of wild-type, while YukBA
K1016A
 and YukBA
K1299A
 are each able to 
complement the biofilm defect of the yukBA-deficient strain (Figure 4-3).  These results parallel 
the energetic requirements for YukE secretion.   
 
When the YukBA ATPase domains are mutated in combination, we find that none of the mutants 
are able to restore biofilm formation by 3610 ∆yukBA to that of wild-type 3610 (Figure 4-3).  
These results suggest that there may be differential energetic requirements for YukE secretion 
versus biofilm formation, as complementation with the YukBA
K1016AK1299A
 mutant fully restores 
YukE secretion, but does not complement biofilm formation.  This data supports our previous 
results demonstrating that the role of the yuk system in biofilm formation is independent of YukE 
secretion.  It is possible that biofilm formation requires the secretion of an as of yet unidentified 
substrate.  Although we did not find evidence of additional yuk substrates in our mass spec 
analysis of the culture supernatants of the laboratory strain B. subtilis PY79, it is conceivable that 
secretion is dependent upon growth condition, or that a substrate(s) may be secreted specifically 
by the B. subtilis 3610 strain.  Alternatively, the yuk system may mediate biofilm formation 
and/or cell wall composition by a mechanism independent of protein secretion. 
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Figure 4-3.  YukBA ATPase activity is required for normal biofilm formation. 
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Figure 4-3 (continued).  B. subtilis 3610 wild-type, ∆yukBA, and ∆yukBA strains complemented 
with YukBA Walker A motif mutants were grown on MSgg agar to induce biofilm growth.  Light 
gray shaded panels indicate a strain which has a wild-type biofilm morphology; dark gray shaded 
panels indicate a strain demonstrating a mutant biofilm morphology.  As diagrammed on the 
bottom left of the figure, left panels: entire biofilm; right panels: close up view of biofilm center.  
Scale bar: 0.5 cm, indicated for each view.   
 
4.3 Discussion 
 
The functions of ESX-type secretion systems are still an area of active discovery.  Here, we 
demonstrate partially differential requirements for EccCa-EccCb ATPase activity in ESX-1-
dependent cell wall integrity versus ESX-1-mediated secretion.  Additionally, we show that the 
comparable functions of the yuk secretion system, YukE secretion, susceptibility to cefuroxime, 
and normal biofilm formation, also differentially rely on ATPase activity.   
 
Though the requirement of ESX-1 for virulence has historically been attributed to the secretory 
function of this system, the recent demonstration that protein secretion can be dissociated from 
virulence highlights the simplicity of this model.  The identification of ESX-1 as a critical 
mediator of bacterial cell wall integrity suggests that the primary target of this system is the 
bacterium itself.  We have found evidence to suggest that ESX-type systems share conserved 
functions of both protein secretion and an involvement in cell wall formation/maintenance.  
Though the extent to which these two functions are connected is not yet understood, the 
differential ATPase requirements for these functions in both Mtb and B. subtilis support previous 
findings that these functions are separable, and suggests that the mechanism by which these 
systems function in secretion and cell wall integrity differ. 
 
Here, we have demonstrated that the most N-terminal Walker A motif of YukBA, YukBA
K688
, is 
required for normal biofilm formation.  Additionally, this nucleotide binding site, as well as the 
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equivalent enzymatic domain in Mtb, EccCa
K485
, is absolutely required for ESX-mediated 
secretion.  Together, these data suggest that this domain may have a conserved function which is 
required for both secretion and cell wall related functions.   
 
In Chapters 3A and 3B, we show that the second and third Walker A motifs of EccCa-EccCb and 
YukBA are differentially required for ESX-mediated secretion.  Here, we find that, within both 
the ESX-1 system and the yuk system, these two domains are differentially required for protein 
secretion versus cell wall related functions.  Together, these results suggest that these two 
domains may have evolved to fulfill both species-specific and function-specific requirements. 
 
4.4 Materials and Methods 
 
Culture of Mtb and B. subtilis 
Mtb (H37Rv) strains were maintained in Middlebrook 7H9 media supplemented with oleic acid-
albumin-dextrose-catalase (OADC, Difco) and 0.05% Tween 80, and when appropriate 50 μg/ml 
hygromycin.  B. subtilis PY79 and 3610 strains were maintained in Miller LB broth (Acros, New 
Jersey, USA) or on Difco Miller LB agar (BD, Sparks, MD).  When appropriate, antibiotics were 
included in the growth media as follows: 100 μg/mL spectinomycin and 1 μg/mL erythromycin 
plus 25 μg/mL lincomycin (mls).   
 
Strain construction 
All strains and complementing constructs (Mtb and B. subtilis) were previously described in 
Chapters 2.4, 3A.4 and 3B.4.  The B. subtilis strains used in this study are listed in Supplemental 
Table 4-1. 
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Mtb detergent susceptibility 
SDS susceptibility assays were performed as previously described (Garces 2010).  Briefly, strains 
were grown to early log phase in Sauton’s media supplemented with 0.05% Tween 80 and 100 
ng/mL AT.  Cells were pelleted, washed once and resuspended at a density of 1.26108 cells/mL 
in 7H9 media containing 0.1% SDS, and 100 ng/mL AT when appropriate.  Bacteria were 
incubated in SDS overnight at 37
o
C with shaking, washed twice and plated in triplicate for CFU 
on 7H10 agar plates containing 10% OADC. 
 
B. subtilis disc plate diffusion assays 
Mid-exponential phase cultures were evenly plated to seed a lawn on LB agar using glass beads.  
When appropriate, IPTG was added into the LB agar at a final concentration of 100 μM to induce 
expression of the complementing construct.  Sterile paper discs were placed on the surface of the 
agar in the center of the petri dish; one disc per plate.  6 μL of the appropriate antibiotic or SDS, 
diluted to the indicated concentration in sterile ddH20, was spotted on each disc.  When dry, 
plates were incubated at 37
o
C overnight.   
 
B. subtilis biofilm assays 
For colony architecture analysis on solid media, a fresh colony was resuspended in 30 μL of PBS; 
2 μL was spotted onto an MSgg plate with 1.5% Bacto agar (Branda 2001) and incubated at 30°C 
for 3 days.  Biofilms were imaged using a Leica Wild M10 camera with a Planapo 0.63x 
objective.   
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4.5 Supplementary Materials 
Strain GenotypeA Source/Reference
PY79 Prototrophic domesticated laboratory strain Youngman 1983
3610 Undomesticated wild strain Branda 2001
bLH018 yukEDCBA::erm-Pyuk, amyE::kan Chapter 2
bLH045 yukE::erm-Pyuk, amyE::kan This Chapter
bLH048 yukEDCBA::erm-Pyuk, amyE::kan This Chapter
bLH108 yukBAyueB::erm This Chapter
bLH109 yueB::erm Chapter 2
bLH110 yukBA::erm-Pyuk Chapter 2
bLH278 3610 yukBA::erm-Pyuk Chapter 2
bLH338 3610 yukBA::erm-Pyuk, amyE::Phyperspank-yukBAK688AK1016A-myc This Chapter
bLH340 3610 yukBA::erm-Pyuk, amyE::Phyperspank-yukBAK688AK1299A-myc This Chapter
bLH342 3610 yukBA::erm-Pyuk, amyE::Phyperspank-yukBAK1016AK1299A-myc This Chapter
bLH344 3610 yukBA::erm-Pyuk, amyE::Phyperspank-yukBAK688AK1016AK1299A-myc This Chapter
bLH346 3610 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-myc This Chapter
bLH348 3610 yukBA::erm-Pyuk, amyE::Phyperspank-yukBAK688A-myc This Chapter
bLH350 3610 yukBA::erm-Pyuk, amyE::Phyperspank-yukBAK1016A-myc This Chapter
bLH352 3610 yukBA::erm-Pyuk, amyE::Phyperspank-yukBAK1299A-myc This Chapter
bLH404 yukBA::erm-Pyuk, amyE::Phyperspank-yukBA-myc Chapter 2
bLH421 yukD::erm-Pyuk Chapter 2
bLH422 yukC::erm-Pyuk Chapter 2
 
 
Supplemental Table 4-1.  Strains used in this study. 
A 
All strains are isogenic with the B. subtilis laboratory wild-type strain PY79 unless otherwise 
indicated; “3610” indicates that the strain is isogenic with the B. subtilis undomesticated wild-
type strain 3610. 
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Despite the importance of the ESX-1 secretion system to Mtb virulence, the primary function of 
this system and the mechanism by which this system mediates virulence is still unclear.  Due to 
the inherent challenges of working with Mtb, researchers can benefit greatly from the 
development of model systems in which to address a wide variety of questions regarding Mtb 
biology.  Here, we describe the development of a B. subtilis model system in which to study the 
function and mechanism of action of ESX-type secretion systems. 
 
We have demonstrated that the yuk locus encodes a secretion system responsible for the secretion 
of YukE.  Additionally, we have found this system to be important for normal biofilm formation.  
These findings are reminiscent of the two identified functions of the Mtb ESX-1 system: protein 
secretion and mediating cell wall integrity.  These results suggest that the dual functionality 
demonstrated by ESX-1 may be a conserved characteristic of ESX-type secretion systems.   
 
ESX-1-mediated cell wall integrity is independent of the secretion of known ESX-1 substrates 
and interestingly, we have found that the role of the yuk system in biofilm formation is 
independent of YukE secretion.  While we have not ruled out the possibility that the yuk system 
mediates biofilm formation through the secretion of an as of yet unidentified protein substrate, 
these data suggest that ESX-type systems may modulate the bacterial cell surface in a conserved, 
secretion-independent manner.  This may be through the transportation of a nonproteinous 
substrate(s), such as lipids or small molecules, or ESX systems may act as an important structural 
scaffold in the cell wall.  To further address whether the role of the yuk system in biofilm 
formation is secretion dependent or independent, we propose to screen for additional substrates 
using the laboratory strain B. subtilis PY79 grown in biofilm-inducing conditions, as well as in 
the undomesticated strain B. subtilis 3610. 
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Here, we have used the B. subtilis model system to investigate the molecular mechanism of ESX-
associated ATPases.   Given the unique multi-FtsK/SpoIIIE domain structure of these ATPases, it 
was unclear how these enzymes assemble into a functional unit and whether each of the three 
ATPase domains of EccCa-EccCb and YukBA are functional.  We have demonstrated that 
YukBA forms a dimer, producing a complex with a hexameric ring of enzymatic domains.  We 
hypothesize that this structural configuration is common to ESX-associated ATPases.  
Additionally, we have demonstrated that each enzymatic domain within these ATPases is 
functional, though not always required, and that all ATPase domains within the enzyme do not 
contribute equally to function.   
 
Our data suggest that the most N-terminal Walker A motif of ESX-associated ATPases may share 
a conserved role acting as the primary source of energy for substrate translocation.  The 
differential requirements for the remaining two ATPase domains of EccCa-EccCb and YukBA 
suggest that these domains may have evolved to fulfill both species-specific and function-specific 
requirements.   
 
We hypothesize that the increased energy requirement of ESX-1-mediated secretion reflects the 
additional complexity in the ESX-1 secretion process as compared to secretion by the yuk system.  
Continued studies are required to test whether this is due to the split protein architecture that 
unique to ESX-1 and ESX-1-encoded ATPases, or if this additional requirement reflects 
differences in substrate interactions or regulation between the two systems. 
 
Future studies using the B. subtilis yuk system as a model ESX-type system, stand to provide 
great insight into the mechanism and function of these systems, both in general, and specifically 
in relation to the role of the ESX-1 system in the pathogenesis of Mtb. 
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